• Advertisement
To advertise, place classifieds free ads by category in a forum as a new topic, or in the classified display ads section, or start a classifieds free blog.

Four people in Oregon who received both doses of vaccine test positive for coronavirus

Whistleblower from Berlin nursing home: the terrible dying after vaccination

Postby smix » Tue Feb 16, 2021 12:08 am

Whistleblower from Berlin nursing home: the terrible dying after vaccination
2020 News

URL: https://2020news.de/en/whistleblower-fr ... ccination/
Category: healthNews
Published: February 14, 2021

Description: For the first time, there is an eyewitness report from a Berlin nursing home on the situation after the vaccination. It comes from the AGAPLESION Bethanien Havelgarten retirement home in Berlin-Spandau. There, within four weeks after the first vaccination with the BioNTech/Pfizer vaccine Comirnaty, eight of 31 seniors, who suffered from dementia but were in good physical condition according to their age before the vaccination, died. The first death occurred after only six days, and five other seniors died approximately 14 days after vaccination. The first symptoms of the disease had already appeared shortly after the vaccination. From information available to 2020News the patients have not been duly informed about the risks of this vaccine. One reason being that no detailed information about the novelty of this mRNA vaccine which has only conditionally been certified in the European Union have been provided. Attorney at Law Viviane Fischer and Attorney at Law Dr. Reiner Füllmich of the Corona Committee spoke in a video interview with the whistleblower about the closer circumstances of the vaccination, the symptoms that occurred and the different nature of the deaths in temporal connection with the vaccination. On January 3, 2021, 31 female and male residents of the dementia ward “ground floor/protected area” had been vaccinated with Comirnaty. Relatives of another three seniors had objected to vaccination, and two residents were in terminal care, so no vaccination was given. The residents of this ward are very active, “self defending” dementia patients who are physically in good condition. They are allowed to move around the ward all day without restriction. The day before the vaccination, the 31 vaccinated persons were all in good health. A few days earlier, all had tested negative for Corona, according to the whistleblower report. According to the whistleblower, the first vaccination event with Comirnaty on January 3, 2021, took place in such a way that all residents were gathered in the recreation room of the first floor area. A vaccination team consisting of an aged vaccinator, three aides and two federal soldiers in camouflage uniforms performed the vaccinations. The home staff as well as the home physician assisted in the process. The role of the soldiers, who at no time moved away from the vaccine, has not been conclusively determined. What the whistleblower was able to establish, however, was that the presence of the uniformed men greatly intimidated the seniors. The group, which normally shows a “strong defensive behavior” in the case of unfamiliar treatments, was hardly recognizable, so predominantly “lamblike” they had let the vaccination with Comirnaty pass over them. The whistleblower suspects that this could also be related to the fact that the elderly seniors, who had still experienced the war, could not properly assess the role of the soldiers and possibly felt reminded of war-traumatic circumstances. During the first vaccination, a resisting senior citizen was detained by a nurse under the watchful eyes of the German soldiers, the eyewitness reported. A judicial decision for the detention, which as such represents a coercion and therefore requires in principle a judicial evaluation in the individual case, had not been issued. According to the whistleblower’s account, the administration of the second vaccination dose took place without warning always on the spot where the person to be vaccinated was found. For example, an elderly lady lying unsuspecthe ingly in bed who began to resist the second dose was restrained by two members of tnursing staff in order to overcome her resistance – again without the necessary court order. The swabbing for the PCR test, which some seniors tried to resist, is also regularly done with the use of physical force against the seniors resisting the unwanted treatment, the whistleblower said. According to the whistleblower, the vaccination education of the caregivers and relatives – the seniors are unable to effectively consent to vaccination due to their dementia – was based on outdated information sheets from the RKI/Grünes Kreuze. In particular, the information required by Regulation (EC) No. 507/2006 on the fact the vaccine Comirnaty has only been granted conditional marketing authorization and why this is the case is missing. In particular, the information should have been provided that from the point of view of the regulatory authority EMA, the data situation still needs to be improved with regard to various aspects, e.g. the interaction of Comirnaty with other drugs. Already on the day of vaccination, four of the vaccinated seniors began to show unusual symptoms. In the evening of that day they were fatigued and extremely tired, some of them fell asleep at the table during dinner. A sharp drop in blood oxygen saturation was noted. In the further course, the leaden fatigue continued, the oxygen saturation in the blood remained insufficient, in some cases gasping breathing occurred, and fever, edema, skin rash, a yellowish-gray discoloration of the skin, and a (characteristic) muscle tremor of the upper body and arms occurred. The seniors also showed a change in demeanor, were partially unresponsive, and refused to eat or drink. One vaccinated senior, who had previously been “in great shape” for her age and suffered from no serious previous illnesses, died as early as January 9, 2021, just six days after vaccination. Deaths among vaccinated seniors and senior citizens occurred on January 15, January 16, January 19 (2 deaths), January 20, February 2, and February 8, 2021. The most recently deceased senior citizen was a former opera singer who had been playing the piano the day before vaccination. The whistleblower reports on the state of health that the old gentleman regularly went jogging, danced, played music and was otherwise very dynamic and active. Of the seniors who tested negative before vaccination, various suddenly showed a positive test result after vaccination. However, all of these seniors did not show any of the known COVID-19 symptoms, i.e., symptoms of colds such as cough, cold, loss of sense of smell and taste, etc. On January 24, 2021, the second dose of Comirnaty was applied to 21 seniors. After this vaccination, according to the whistleblower, eleven seniors are now showing persistent extreme fatigue, partially gasping for breath, partially edema, skin rash, and the yellowish-grayish skin discoloration. As of February 10, 2021, none of the seniors who received the second dose of Comirnaty has died, but the health of some of the seniors in this group is steadily deteriorating. The whistleblower impressively describes the different nature of the dying process of the vaccinated. Normally, the person dying would eventually accept their approaching death and – perhaps after seeing a loved one for the last time – go in peace. Dying as after vaccination, however, was different, he said. It is “inhumane.” The old people he had seen dying had breathed heavily, trembled strongly, and seemed as if inwardly they had passed away already. It seemed to him like a lonely, futile struggle against death, as if “the people knew that their time had not yet come, and therefore they had not yet been able to let go.” The AGAPLESION Bethanien Havelgarten senior citizens’ residential home was requested to comment on the events on February 3, 2021 by Attorney at Law Viviane Fischer, in the name and on behalf of two journalists researching the topic, but has still not received a response. Attorney at Law Viviane Fischer filed a criminal complaint with the public prosecutor’s office on February 3, 2021, 12:04 a.m., and informed the police as well as Prof. Klaus Cichutek, the head of the Paul Ehrlich Institute, which is responsible for recording vaccination side effects, and the Senator for Health of Berlin, Dilek Kalayci, about the events. The health department was also informed, as well as the office of the senate administration responsible for nursing homes. Lawyer Fischer requested the public prosecutor’s office to secure the body of the last deceased old gentleman, She alerted the officials to the imminent death of the eighth death victim, which was to be feared at that time promptly. In the meantime he succumbed to his illness. Upon telephone inquiry on February 8, 2021, the file could not be found in the registry at the public prosecutor’s office. Such a registration, so it was communicated, can in Corona times take up to six weeks. On February 8, 2021 Attorney a Law Fischer has therefore additionally filed a criminal complaint via the Internet guard of the Berlin police. A press inquiry with view of initiated investigations, seizure of the corpses and possible similar occurrences in the past examined by the authorities, which Attorney at Law Fischer had placed again in agency of the two journalists on February 8, 2021, answered the police in the evening of February 9, 2021, as follows: “So far the Berlin police led no investigations in connection with the deaths described by you. Such investigations are always initiated when a doctor certifies a non-natural cause of death when issuing the death certificate. The two deaths you mentioned are also not known to the Berlin police. In this respect, no investigations were conducted nor has the body of the deceased been seized. The criminal charges filed by you are available to the Berlin police and are currently being investigated by a specialist department of the criminal police or by the Berlin public prosecutor’s office. Information for this can be received from the press office of the public prosecutor’s office in Berlin.” The investigation behavior of the police presenting itself at present as little engaged stands in contrast to the legality principle and pursuit obligation for criminal offences, to which police and public prosecutor are subject, Attorney at Law Dr. Fuellmich states. A violation of this could justify the reproach of an obstruction of justice in the office pursuant to § 258 a StGB.§ Section 160 (I) sentence of the Code of Criminal Procedure stipulates: “As soon as the public prosecutor’s office becomes aware of the suspicion of a criminal offense through a report or by other means, it must investigate the facts of the case in order to decide whether to file a public complaint.” Section 163 (I) sentence 1 of the Code of Criminal Procedure stipulates: “The authorities and officers of the police service must investigate criminal offenses and issue all orders that do not permit any delay in order to prevent the case from becoming obscure. It would therefore be contrary to current law for the police to take action only when the family doctor, emergency physician or even the vaccinator himself filling out the death certificate confirmed an unnatural cause of death. It was already questionable whether an external physician, who in case of doubt could not know the medical history in detail, would at all be able to assess the situation and the dying process correctly. According to Dr. Fuellmich, the lawyer, there is undoubtedly a considerable initial suspicion that the extraordinary accumulation of deaths – otherwise only one or two seniors die per month in the respective department of the nursing home – was not due to natural causes. With regard to the eleven seniors whose health condition had deteriorated after administration of the second dose of Comirnaty, there was also imminent danger. The police, the health offices and the senate administration have a guarantor position to avert danger for the population. If the persons installed to fend off danger from the public do not follow their obligation, a punishability of the acting persons because of active assistance and/or assistance by omission to the body injury (possibly even with death consequence) – committed while in office – comes into consideration, Attorney at Law Fischer states. Also a negligent act participation must be examined. In order to avoid dangers for possible future victims the police is obligated to immediately start professional investigations. Post-mortem examinations must be carried out. A retreat to a possible theoretical assessment of police experts, as this was indicated to Attorney at Law Fischer by the police department in charge (LKA 115, offenses against humans), could not be accepted. The question, which symptoms develop after a vaccination and possibly cause the death of the patient can at present not be answered by any expert simply because up-to-date no study exists for instance regarding the endangerment of old humans by the vaccine. In particular no interaction studies regarding other medicines have been performed. After deaths in Norway following the Corona vaccination, the vaccination of very old, fragile people is no longer recommended in Norway. The causal relationship between vaccination and the accumulation of deaths, especially among the elderly, is such that government action is urgently needed to protect the health and lives of all those willing to be vaccinated and those who have already received a dose of Comirnaty. The precautionary principle may include temporarily suspending the use of this vaccine for the duration of a full and transparent investigation into any role it may have played in the deaths of the elderly whose fates are the subject of this article. These governmental measures should also be taken, in particular, for the benefit of those who wish to visit vaccination centers, are residents of retirement or nursing homes, or have a job in health care with contact with patients. Comirnaty seems by no means as safe as one might think based on the government’s vaccination campaign and the many public statements by politicians and experts who support the government’s lockdown course. Comirnaty is a so-called mRNA (messenger ribonucleic acid) vaccine. The mRNA contains the “blueprint” for a protein on the surface of SARS-CoV-2. Through vaccination, this blueprint enters the body cells of the vaccinated person via tiny fat particles (fat nanobodies). These are then supposed to produce a protein that is found on the surface of the virus. This is intended to induce a response in the immune system that will in turn cause an appropriate immune response to occur in the event of subsequent infection with SARS-CoV-2. Because of the unusually short duration of clinical testing on humans, it is obvious from the point of view of 2020news.de that not all possible negative effects of this vaccine could be researched. In particular, experts believe there is a risk of the formation of antibody-dependent enhancement (ADE). This is the term used to describe antibodies that bind to the surface of viruses but do not neutralize them, instead leading to enhanced uptake of the virus into a cell and thus promoting the spread and multiplication of the virus. Infection-enhancing antibodies promote immunopathogenesis and constitute a long-known potential hazard of certain vaccines. The occurrence of this hazard has been well documented for previous unsuccessful attempts to develop vaccines against coronaviruses (such as SARS-CoV). In some preclinical animal studies, test animals became severely ill or even died after encountering the wild virus because of the appearance of infection-boosting antibodies. Experts also fear that the occurrence of autoimmune diseases and an impairment or endangerment of fertility, pregnancy, unborn life, breastfeeding with breast milk and children whose mothers were vaccinated during pregnancy cannot be ruled out. In their view the probability of the occurrence of these negative consequences could not – or not sufficiently – be investigated due to the design of the clinical trials in humans, which BioNTech/Pfizer conducted before the conditional approval of Comirnaty. According to the assessment of the Paul Ehrlich Institute, the polyethylene glycol (PEG)-containing lipid nanoparticles contained in Comirnaty may, too, be possible triggers of observed serious reactions in connection with the vaccination. This is also troubling because in numerous preclinical studies, PEG liposomes have been shown to transport substances across the blood-brain barrier. Certain liposomes have also been linked to the death of specific cells in the liver and lungs in animal studies. For more details, see the recording of Corona Committee Meeting #37 (starting at 03:55:00). According to the EMA Dashboard, as of February 12, 2021, 54,828 adverse vaccine reactions have already been reported. As of January 31, 2021, there were 26,849. Because of the multiple concerns about the vaccine, a withdrawal request against the approval has already been submitted to the EMA. According to lawyer Fischer, Attorney at Law Dr. Renate Holzeisen will file an action against this approval, including summary proceedings, with the European Court of Justice (ECJ) in due time on behalf of clients residing in Italy. Such an action and such an application is possible within a period of two months after the conditional approval of Cominarty had been granted. According to lawyer Fischer, these proceedings will now also be accompanied by an international network of lawyers and scientists, to which the members of the Corona Committee also belonge. The judgment in the main proceedings and the decision in the summary proceedings will have an impact in all member states of the EU for which the conditional approval of Comirnaty has effect. On February 12, 2021, the public prosecutor informed Attorney at Law of the European Union (EU) of the European Commission (EU) of the European Commission’s decision in the matter of the European Commission’s decision in the matter of the European Commission’s decision in the matter. This, in turn, is intended to induce a response in the immune system that will cause an appropriate immune response to occur in the event of subsequent infection with SARS-CoV-2. Because of the unusually short duration of clinical testing on humans, it is obvious from the point of view of 2020news.de that not all possible negative effects of this vaccine could be researched. In particular, experts believe there is a risk of the formation of antibody-dependent enhancement (ADE). This is the term used to describe antibodies that bind to the surface of viruses but do not neutralize them, instead leading to enhanced uptake of the virus into a cell and thus promoting the spread and multiplication of the virus. Infection-enhancing antibodies promote immunopathogenesis and constitute a long-known potential hazard of certain vaccines. The occurrence of this hazard has been well documented for previous unsuccessful attempts to develop vaccines against coronaviruses (such as SARS-CoV). In some preclinical animal studies, test animals became severely ill or even died after encountering the wild virus because of the appearance of infection-boosting antibodies. Experts also fear that the occurrence of autoimmune diseases and an impairment or endangerment of fertility, pregnancy, unborn life, breastfeeding with breast milk and children whose mothers were vaccinated during pregnancy cannot be ruled out – in particular because the probability of the occurrence of these negative consequences could not be investigated or not sufficiently investigated due to the design of the clinical trials in humans, which BioNTech/Pfizer conducted before the conditional approval of Comirnaty. According to the assessment of the Paul Ehrlich Institute, the polyethylene glycol (PEG)-containing lipid nanoparticles contained in Comirnaty may also be possible triggers of observed serious reactions in connection with the vaccination. This is also troubling because in numerous preclinical studies, PEG liposomes have been shown to transport substances across the blood-brain barrier. Certain liposomes have also been linked to the death of specific cells in the liver and lungs in animal studies. For more details, see the recording of Corona Committee Meeting #37 (starting at 03:55:00). According to the EMA Dashboard, as of February 4, 2021, 41,140 adverse vaccine reactions have already been reported. As of January 31, 2021, there were 26,849. Because of the multiple concerns about the vaccine, a withdrawal request against the approval has already been submitted to the EMA. According to attorney Fischer, attorney Dr. Renate Holzeisen will file an action against this approval, including summary proceedings, with the European Court of Justice (ECJ) in due time on behalf of clients residing in Italy. Such an action and such an application would be possible within a period of two months after the conditional approval of Cominarty had been granted. These proceedings would now also be accompanied by an international network of lawyers and scientists, to which the members of the Corona Committee also belonged. The judgment in the main proceedings and the decision in the summary proceedings will have an impact in all member states of the EU for which the conditional approval of Comirnaty has effect. On February 12, 2021, the public prosecutor informed attorney Viviane Fischer in writing: “Your criminal complaint is already known here, but not yet recorded in our system, so I cannot provide you with any further information on this at present. However, within the scope of the permissible investigations, everything necessary will be arranged with the necessary acceleration.”



Thrombosis, heart attacks and cerebral hemorrhages are possible after all vaccines
2020 News

URL: https://2020news.de/thrombosen-herzinfa ... -moeglich/
Category: healthNews
Published: March 27, 2021

Description: Translated from German
Coronaviruses and their spikes do not get into the blood if the infection is uncomplicated. The immune barriers in the upper respiratory tract prevent this from all mild respiratory tract infections, not just for coronaviruses *.However, this is bypassed by injecting genetic “vaccines” into the muscles of the upper arm. There are then three possible risks of vaccinations that can have similar serious consequences **:
1. After intramuscular injection, it must be expected that the gene-based vaccines can enter the bloodstream and then spread throughout the body [1; 2] In such cases, it must then be expected that the vaccines will be distributed in the bloodstream and absorbed by endothelial cells. These are the cells that line blood vessel walls. It can be assumed that such uptake in endothelial cells occurs particularly in places with slow blood flow, i.e. in small vessels and capillaries. When this happens, the genetic information of the vaccines (e.g. mRNA) will cause those endothelial cells to produce parts of spike proteins and present them on their surfaces to the blood cells flowing by. Many healthy people have CD8 lymphocytes that patrol the blood and recognize such corona spike peptides, which can be attributed to a previous COVID infection, but also to cross-reactions with other types of coronavirus [3; 4] [5]. We have to assume that these CD8 lymphocytes start an attack on the corresponding cells upon contact. This can damage the vascular wall in innumerable places in the body with subsequent triggering of blood clotting through activation of the blood platelets (thrombocytes). So this happens when the vaccine gets into the blood itself. Two further risks arise if it is not the vaccine and its genetic information, but the spike proteins or parts of them that are induced by our body and produced in our cells, which are released into the blood.
2. When such SARS-CoV-2 spike proteins, which are genetically engineered in our cells, get into the blood, they connect directly to the ACE2 receptors of the platelets, which also leads to blood clots and thrombosis [6] [7]. This has also been observed with whole coronaviruses, which in rare cases get into the blood. Thrombocytopenia that developed in this way has also been reported in vaccinated people [8] [9] [10].
3. In addition, there is the ability of the SARS-CoV-2 spike proteins to initiate cell fusions very strongly. The resulting giant cells can also lead to vascular obstruction, inflammatory reactions and microthromboses. (11)
What can be the result of all three causes:
In blood tests, this can be seen from the drop in platelet count and the appearance of D-dimers (fibrin breakdown products) in the blood. Clinically, there can be innumerable damage as a result of circulatory disorders throughout the body, including the brain, spinal cord, and heart. Because of such consumption of coagulation factors and blood platelets, bleeding can also occur in various organs and, for example, have fatal consequences in the brain. It is important to note that for all of the options mentioned that can lead to disseminated intravascular coagulation (DIC), all three vaccines lack evidence that they were excluded by the EMA before they were approved for use in humans.
--
Editor's note: On March 16, 2021, after the occurrence of seven cerebral vein thromboses, an extremely rare disease, the Paul Ehrlich Institute initially suspended the use of the AstraZeneca vaccine four to 16 days after the vaccination . However, the EMA, which is responsible for the European supervision of the vaccines, denied any connection with the vaccination within 48 hours.
* The patients admitted to the clinics with atypical virus infections mostly also have multiple infections (12), which unfortunately are rarely clarified through differential diagnostics, especially in times of fixation on Covid-19.
** The first two questions presented were also put to the European Medicines Agency on February 28, 2020 by an international group of scientists.
--
References:
[1] Hassett, KJ; Benenato, KE; et al. (2019). Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines, Molecular therapy. Nucleic acids 15: 1-11.
[2] Chen, YY; Syed, AM; MacMillan, P .; Rocheleau, JV and Chan, WCW (2020). Flow Rate Affects Nanoparticle Uptake into Endothelial Cells, Advanced materials 32: 1906274.
[3] Grifoni, A. et al. (2020). Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, Cell 181: 1489-1501.e15.
[4] Nelde, A .; Bilich et al. (2020). SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition, Nature immunology.
[5] Sekine, T. et al. (2020). Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, Cell 183: 158-168.e14.
[6] Zhang, S .; Liu, Y .; Wang, et al. (2020). SARS-CoV-2 binds platelet ACE2 to promote thrombosis in COVID-19, Journal of hematology & oncology 13: 120.
[7] Lippi, G. et al. 2019 (COVID-19) infections: A meta-analysis, Clin. Chim. Acta 506: 145-148.
[8] Grady, D. (2021). A Few Covid Vaccine Recipients Developed a Rare Blood Disorder, The New York Times, Feb. 8, 2021.
[9] Geoffrey D. Wool ,: The Impact of COVID-19 Disease on Platelets and Coagulation, DOI: 10.1159 / 000512007
[10] Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020 Jun; 127: 104362.
[11] Theuerkauf et al., IScience 24, 102170, March 19, 2021
[12] Nickbakhsh, Sema, (2019) Virus-virus interactions impact the population dynamics of influenza and the common cold, https://www.pnas.org/cgi/doi/10.1073/pnas.1911083116
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

Dr. Sherri Tenpenny Explains How the mRNA Injections Might Cause Mass Deaths 3-6 Months After Being Injected

Postby smix » Tue Feb 16, 2021 1:50 am

Dr. Sherri Tenpenny Explains How the mRNA Injections Might Cause Mass Deaths 3-6 Months After Being Injected
Humans Are Free

URL: https://humansarefree.com/2021/02/dr-sh ... ected.html
Category: healthNews
Published: February 12, 2021

Description: Dr. Sherri Tenpenny gives VERY important information! Hyper-immune response in test animals for previous attempts at coronavirus vaccines, like SARS and MERS, has been a persistent problem. All is well for awhile, until the animals are exposed to the wild mutated virus. Dr. Tenpenny and other scientists have forecast that millions may die, and it will be blamed on a new strain of COVID, making an argument for even more deadly vaccines.





Dr. Lee Merritt: In Animal Studies, After Being Injected With mRNA Technology, All Animals Died Upon Reinfection
Humans Are Free

URL: https://humansarefree.com/2021/01/dr-le ... -died.html
Category: healthNews
Published: January 29, 2021

Description: In the following interview, Dr. Lee Merritt explains that mRNA technology is not a vaccine, mirroring what Dr. David Martin also stated recently. In animal studies, after mRNA injections have been administered to cats, when the virus arrived once again into the body, it arrived like a Trojan Horse, undetected by the cats’ own immune system. The virus multiplied unchallenged and all animals involved in the experiment died from various causes. Watch below:



According to Dr. Lee Merritt,
What happened is all animals died… but they didn’t died of the “vaccine”. What they died from what used to be called “immune enhancement” and now they call it “antibody dependent enhancement” (ADE). Here’s what happens: They make the RNA and you get the “vaccine” and you do fine. Now, you challenge the animal with the virus that you are supposed to be immunizing against. So when they challenged those cats with SARS [a.k.a. SARS-CoV-1, is a coronavirus species], instead of killing the virus or weakening it, the immune response that they built into your system when out and codded the virus, so the virus came into the cat’s body like a Trojan Horse, unseen by the cat’s own immune system, and then it replicated without checking and killed the cat with overwhelming sepsis and cardiac failure. And that [also] happened in ferrets, that happened every time they tried this. Let me just point out. We have never made it through an animal study successfully for this type of virus. We have never done this in humans before… We don’t really have a track record of success. This vaccine was rolled out to distribution centers before they even made a show of caring about the FDA approving it. Do you realize that? I’ve never seen that happen before.

User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

EXCLUSIVE-Pfizer withdraws application for emergency use of its COVID-19 vaccine in India

Postby smix » Tue Feb 16, 2021 1:46 pm

EXCLUSIVE-Pfizer withdraws application for emergency use of its COVID-19 vaccine in India
Reuters

URL: https://www.reuters.com/article/health- ... SL4N2KB1NZ
Category: healthNews
Published: February 5, 2021

Description: NEW DELHI, Feb 5 (Reuters) - Pfizer Inc has withdrawn an application for emergency-use authorization of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday. The U.S. company, which was the first drugmaker to apply for emergency use authorization of its COVID-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said. “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” it said in a statement to Reuters. “Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.” Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research. Both companies had applied for approval of their vaccines after Pfizer. India’s Central Drugs Standard Control Organisation had declined to accept Pfizer’s request for approval without a small local trial on the vaccine’s safety and immunogenicity for Indians, Reuters has reported. Indian health officials say they generally ask for so-called bridging trials to determine if a vaccine is safe and generates an immune response in its citizens whose genetic makeup can be different from people in Western nations. There are, however, provisions under India’s New Drugs and Clinical Trial Rules, 2019, to waive such trials in certain conditions.



Pfizer earlier told Reuters its application was supported by data from a global study that showed an overall efficacy rate of 95% with no vaccine-related, serious safety concerns.



AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times
Reuters

URL: https://www.reuters.com/article/us-astr ... SKCN2AS0RO
Category: Business
Published: February 28, 2021

Description: (Reuters) - AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company’s shares soared on the back of its coronavirus vaccine breakthrough, The Times reported. The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna. AstraZeneca and Moderna did not immediately respond to requests for comment. AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added. Moderna, whose vaccine is cleared for emergency use against COVID-19 in the United States, said last week it was expecting sales of $18.4 billion from its coronavirus vaccine this year.





WHO panel issues strong advice against hydroxychloroquine for COVID-19
Reuters

URL: https://www.reuters.com/article/idUSKCN2AU00H
Category: Politics
Published: March 2, 2021

Description: (Reuters) - The drug hydroxychloroquine, once touted by Donald Trump as a pandemic “game-changer”, should not be used to prevent COVID-19 and has no meaningful effect on patients already infected, a World Health Organization expert panel said on Tuesday.



The anti-inflammatory drug should not be used in the fight against the pandemic, the WHO’s Guideline Development Group (GDG) expert panel wrote in the BMJ British medical journal, and is “not worthwhile” exploring in further research studies of possible COVID-19 treatments. This “strong recommendation”, the experts said, is based on high-certainty evidence from six randomised controlled trials involving more than 6,000 participants both with and without known exposure to COVID-19.



Former U.S. President Trump said last March that hydroxychloroquine could be a game-changer in the coronavirus pandemic. He also said he was taking it himself, even after the U.S. medicines regulator, the Food and Drug Administration (FDA), advised that its efficacy and safety were unproven. But the WHO’s experts said they now “judged that almost all people would not consider this drug worthwhile”. “The panel considers that this drug is no longer a research priority and that resources should rather be oriented to evaluate other more promising drugs to prevent COVID-19,” they wrote. The WHO noted in a statement that the recommendation is a so-called “living guideline” on potential drugs for COVID-19.

tedros-gates-ready.jpg

The guidelines, which can be updated as new evidence emerges, are designed to advise doctors and healthcare providers on managing the respiratory disease and help them make better decisions for patients.



Woman dies from brain haemorrhage in Japan days after vaccine, but link uncertain
Reuters

URL: https://www.reuters.com/article/idUSKBN2AU17Y
Category: Politics
Published: March 2, 2021

Description: TOKYO (Reuters) - A Japanese a woman in her 60s died from a brain haemorrhage three days after receiving a Pfizer coronavirus vaccination, the health ministry said on Tuesday, adding that there may not be a link between the two. The woman was vaccinated on Friday and is suspected to have suffered a brain haemorrhage three days later, on Monday, it said. It was Japan’s first reported death following a vaccination. “The brain haemorrhage that is suspected as a cause is relatively common among people from their 40s to their 60s, and at this time, based on examples overseas, there does not seem to be a link between brain haemorrhages and the coronavirus vaccine,” the ministry quoted Tomohiro Morio, a doctor advising the government, as saying. “It may be a coincidental case, but there is a need to gather more information and make an assessment in upcoming working groups.”



Pfizer officials in Japan were not immediately available for comment. Pfizer said in November the efficacy of its vaccine was consistent across age and ethnic groups, and that there were no major side effects, a sign that the immunisation could be employed broadly around the world. Global health authorities have praised the fast development of safe and effective COVID vaccines, but have warned people with serious underlying health conditions to take medical advice first. Japan became the last member of the Group of Seven leading industrialised nations to begin its vaccination drive, on Feb. 17. It has so far received three shipments of vaccine developed by Pfizer and BioNTech. Japan officially approved Pfizer’s vaccine last month, the first such approval in the country as it steps up efforts to tame infections in the run-up to the Summer Olympics.



Supreme Court rules for vaccine makers on lawsuits
Reuters

URL: https://www.reuters.com/article/idUSTRE71L41420110222
Category: Legal
Published: February 22, 2011

Description: WASHINGTON (Reuters) - The Supreme Court ruled that federal law shields vaccine makers from product-liability lawsuits in state court seeking damages for a child’s injuries or death from a vaccine’s side effects. The high court on Tuesday ruled for Wyeth, which is now owned by Pfizer Inc, in a lawsuit brought by the parents of Hannah Bruesewitz, who suffered seizures as an infant after her third dose of a diphtheria-tetanus-pertussis (DTP) vaccine in 1992. Pfizer and other vaccine makers had argued that a Supreme Court ruling for the plaintiffs could open the door to a flood of lawsuits -- many by families who believe vaccines cause autism -- and threaten the supply of childhood vaccines. Pfizer Executive Vice President and General Counsel Amy Schulman said the company was pleased with the ruling. “The Vaccine Act that Congress enacted nearly 25 years ago appropriately places the responsibility for determining the optimal design of life-saving childhood vaccines in the hands of expert federal agencies, not a patchwork of state tort systems,” she said. At issue in the ruling was the National Childhood Vaccine Injury Act of 1986, a law that created a special program to handle disputes in an effort to ensure a stable vaccine supply by shielding companies from most lawsuits. The federal program, involving what is known as the vaccine court, has awarded more than $1.8 billion for vaccine injury claims in nearly 2,500 cases since 1989. It is funded by a tax on vaccines. In the Hannah Bruesewitz case from Pennsylvania, her parents claimed in their lawsuit that her seizure disorder and serious developmental delay stemmed from toxins in the vaccine’s design. They said a safer alternative had been available but was not used. The DTP vaccine was taken off the market in 1998. Russell and Robalee Bruesewitz said their daughter was a healthy infant until she received the shot, but has experienced seizure disorders and developmental problems ever since, requiring a lifetime of supervision and care.
WYETH HAS DENIED VACCINE CAUSED INJURIES
Wyeth has denied its vaccine caused her injuries. After the couple’s claims were rejected under the federal compensation process, they filed a lawsuit in state court. But a federal judge and then a federal appeals court based in Philadelphia ruled the 1986 federal law barred such lawsuits. The Supreme Court, in a majority opinion by Justice Antonin Scalia, upheld that decision and ruled the federal law pre-empted all such design-defect claims against vaccine manufacturers. “Vaccine manufacturers fund from their sales an informal, efficient compensation program for vaccine injuries; in exchange they avoid costly tort litigation and the occasional disproportionate jury verdict. Congress enacted this deal to coax manufacturers back into the vaccine market,” Scalia said. The ruling accepted the Obama administration’s position.

Bill-Gates-Africa.jpg

O. Marion Burton, president of the American Academy of Pediatrics, which represents 60,000 pediatricians, applauded the ruling. “Today, the U.S. Supreme Court affirmed what pediatricians have been advocating for decades,” Dr. Burton said. “Vaccines save lives.”



Exclusive: China gene firm providing worldwide COVID tests worked with Chinese military
Reuters

URL: https://www.reuters.com/article/us-chin ... SKBN29Z0HA
Category: Politics
Published: January 30, 2021

Description: SYDNEY (Reuters) - BGI Group, the world’s largest genomics company, has worked with China’s military on research that ranges from mass testing for respiratory pathogens to brain science, a Reuters review of research, patent filings and other documents has found. The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI’s links to the People’s Liberation Army (PLA) include research with China’s top military supercomputing experts. The extent of those links has not previously been reported. BGI has sold millions of COVID-19 test kits outside China since the outbreak of the new coronavirus pandemic, including to Europe, Australia and the United States. Shares of BGI Genomics Co, the company’s subsidiary listed on the Shenzhen stock exchange, have doubled in price over the past 12 months, giving it a market value of about $9 billion. But top U.S. security officials have warned American labs against using Chinese tests because of concern China was seeking to gather foreign genetic data for its own research. BGI has denied that. The documents reviewed by Reuters neither contradict nor support that U.S. suspicion. Still, the material shows that the links between the Chinese military and BGI run deeper than previously understood, illustrating how China has moved to integrate private technology companies into military-related research under President Xi Jinping.

biden-xi-giggle.jpg

The U.S. government has recently been warned by an expert panel that adversary countries and non-state actors might find and target genetic weaknesses in the U.S. population and a competitor such as China could use genetics to augment the strength of its own military personnel. BGI has worked on PLA projects seeking to make members of the ethnic Han Chinese majority less susceptible to altitude sickness, Reuters found, genetic research that would benefit soldiers in some border areas. Elsa Kania, an adjunct senior fellow at the Center for a New American Security think tank, who has provided testimony to U.S. Congressional committees, told Reuters that China’s military has pushed research on brain science, gene editing and the creation of artificial genomes that could have an application in future bioweapons. She added that such weapons are not currently technically feasible. BGI’s pattern of collaboration with the Chinese military was a “reasonable concern to raise” for U.S. officials, said Kania. In response to Reuters’ questions, BGI said it adheres to international standards and Chinese laws related to open science, data sharing and genomic research. It said its collaboration with military researchers was for academic purposes only. “BGI strongly rejects any accusations about links with the PLA, particularly in relation to our COVID-19 test kits,” it said in a statement. China’s defence ministry did not respond to requests for comment.
‘ENHANCE’ SOLDIER STRENGTH
Chinese technology companies have come under increasing scrutiny by the United States and were subject to mounting restrictions under the administration of Donald Trump. In November, the Department of Commerce proposed a rule to add gene editing software to the U.S. export control list, saying it could be used to create biological weapons. Officials in the new administration of President Joe Biden have signalled a continued tough approach to what they see as a rising threat from Beijing. A technology industry panel on artificial intelligence, appointed by the U.S. government and chaired by former Google Chief Executive Eric Schmidt, raised the alarm in October about China’s financial support for its biotechnology sector, its advantages in collecting biological data, and the PLA’s interest in potential military applications. The panel, which will deliver its final report in March, warned about adversaries using artificial intelligence to identify genetic weaknesses in a population and engineering pathogens to exploit them, and genetic research designed to enhance soldiers’ mental or physical strength. The panel recommended that the U.S. government “take a more aggressive public posture regarding BGI,” citing national security risks posed by the company’s links to the Chinese government and its trove of genomic data. The U.S. Department of State did not immediately respond to a request for comment on Reuters’ findings. In response to Reuters’ questions, China’s foreign ministry said the U.S. government had “wantonly misinterpreted and smeared China’s military-civil fusion policy,” and was imposing unreasonable sanctions that would hamper research. “China’s military-civil fusion policy is aimed at effectively mobilizing military and civilian resources, coordinating socio-economic growth and national defense development, and benefiting the public with scientific and technological progress. This policy is above board and beyond reproach,” the ministry said in a statement to Reuters. It added that this was “customary international practice” and said the U.S. government had effectively pursued military-civil fusion for more than 100 years.
‘KEY PROJECTS’
BGI Group, based in Shenzhen, has grown quickly by selling genetic sequencing services to universities and health systems around the world and amassing a large DNA databank. It created China’s first cloned pig in 2010. One science paper authored by BGI founders Yang Huanming and Wang Jian along with the PLA’s Key Laboratory of High Altitude Medicine and the Third Military Medical University focused on experiments with the brains of monkeys suffering altitude sickness. The study, published in January 2020, stated that it was funded as one of the “key projects of military science and technology” by the PLA. A decade ago, the military university’s research sought to identify genes related to altitude sickness so the PLA could screen for susceptible soldiers. The latest research focused on how drugs interacting with genes could potentially protect a person from brain injury. An earlier 2017 study designed by BGI’s Wang and published in conjunction with a PLA research centre in Xinjiang looked at the effect of rapid mountain ascent on the bodies of “young, healthy men.” China has the world’s longest highland border, which includes its border with India, where fighting broke out between the two countries’ troops in 2020. A 2018 paper by the same PLA laboratory stated that “high altitude disease is the main reason for reduced combat effectiveness and health damage to soldiers at high altitudes and influences the results of war.” Reuters was unable to contact Yang and Wang. BGI said its research collaboration with the PLA lab and the Third Military Medical University, where Yang has been a professor for almost two decades, was “for academic purposes only.”
SEQUENCING COVID
BGI jointly holds a dozen patents for tests that screen for genomes linked to disease with the military university, the PLA’s Academy of Military Medical Science, which is the top medical research institute of the PLA, and PLA hospitals. One patent was granted in 2015 to BGI and the Academy of Military Medical Science for a low-cost test kit to detect respiratory pathogens, including SARS (Severe Acute Respiratory Syndrome) and coronaviruses. BGI’s current chief infectious disease scientist, Chen Weijun, is listed as an inventor on the patent documents. Chen was among the first scientists to sequence COVID-19, taking samples from a military hospital in Wuhan, according to sequence data later shared internationally. Chen is listed as affiliated with the Academy of Military Medical Science in three science papers reviewed by Reuters.In response to Reuters’ questions, BGI said in a statement that Chen has not been affiliated with the PLA’s Academy of Military Medical Science since 2012. Chen did not respond to a request for comment. BGI’s COVID-19 test kit did not use the method jointly patented with the PLA, the company said in the statement. Four BGI researchers have also been jointly affiliated with another military institution, the National University of Defence Technology (NUDT), according to publicly available science and conference papers reviewed by Reuters. Hunan-based NUDT is under the direct leadership of China’s Central Military Commission, the top-level body that steers the Chinese military and is headed by Xi. The NUDT is on a U.S. blacklist as a threat to national security because its Tianhe-2 supercomputer - one of the world’s most powerful - is used to simulate nuclear explosions, according to a Department of Commerce listing. That listing restricts U.S. companies from supplying NUDT with technology. One researcher, Peng Shaoliang, was instrumental in developing software to speed up BGI’s sequencing of human genomes using supercomputing developed by NUDT. Peng has won military awards for his work. He is a member of an expert group advising the Central Military Commission’s Science and Technology Commission, set up in 2016 when Xi began promoting a strategy to integrate China’s civilian and military research. Patent applications in 2020 show Peng is also a member of the PLA’s Institute of Military Medicine. Liao Xiangke, the head of the NUDT’s supercomputer programme and a major general in the PLA, has published seven scientific papers either co-authored with BGI researchers or crediting them for providing data and source code. BGI said in a statement to Reuters that Peng and Liao “were two collaborators of BGI for the project at the time for the purpose of academic exchange only. Since the project ended BGI has no more affiliation with them.” Peng and Liao did not respond to requests for comment. BGI said it uses Tianhe-2 on a commercial basis, as well as other supercomputing platforms, to speed up research. The papers it wrote with the NUDT were for academic purposes only, it said, and were open for public reference, while the programmes themselves have ended. Tianhe-2 has also been used to solve pharmaceutical, cryptology, engineering and climate problems that have no military application, the company said.

BGI and the Bill & Melinda Gates Foundation Sign Memorandum of Understanding on Collaboration for Global Health and Agricultural Development
PR Newswire

URL: https://www.prnewswire.com/news-release ... 39691.html
Category: Press-Releasee
Published: September 25, 2012

Description: SEATTLE and SHENZHEN, China, Sept. 25, 2012 /PRNewswire/ -- BGI, the world's largest genomics organization, announced today that it and the Bill & Melinda Gates Foundation have signed a Memorandum of Understanding (MOU) to form a collaboration on global health and agricultural development with the goal of achieving common objectives in health and agricultural development, and meaningfully contributing to the achievement of one or more of the Millennium Development Goals. The signing ceremony, attended by Dr. Jian Wang, Director and Co-founder of BGI; Dr. Jun Wang, Executive Director, BGI; and Bill Gates of the Gates Foundation, was conducted yesterday outside of Seattle, Washington. Pursuant to the MOU, BGI and the Gates Foundation will collaborate on both a strategic level and a specific project level. Collaboration on specific projects will leverage the Gates Foundation's agriculture and global health program knowledge and networks with BGI's sequencing and genomics capabilities to achieve the goal of significantly reducing poverty and/or improving health outcomes in the developing world. Strategic objectives include identifying a program of work and collaboration across global health and agricultural development and to conduct work together on initial projects with near-term potential to further develop the working relationship between BGI and the Gates Foundation. The agreement supports the prompt and broad dissemination of information from collaboration projects. It also supports broad access to any technology arising from a project. These technologies will be required to be made available at a reasonable cost to the poor. "BGI greatly welcomes this opportunity to partner with the Bill & Melinda Gates Foundation to bring the benefit of genomics research to our global society," stated Dr. Huanming Yang, Chairman and Co-Founder of BGI. "We are confident that the combination of our respective capabilities, expertise and experience will yield important scientific breakthroughs in the areas of human, plant and animal genomics that will contribute to the advancement of sustainable health and agriculture development, especially in the developing world." "Having contributed to the Human Genome Project as well as sequencing the genomes of many critical plant and animal species and human diseases, including the initial sequencing of the rice genome as well as our involvement in the Rice 10,000 Genome Project, the 1,000 Plants and Animals Genome Project, the International 1,000 genomes project, the 1,000 Rare Diseases Project, the International Cancer Genome Project, Autism Genome 10K, among others, BGI looks forward to partnering with the Bill & Melinda Gates Foundation in this significant collaboration to apply genomics research to benefit global human health," stated Dr. Jian Wang. "We work closely with partners like BGI to enable breakthroughs in science that will prevent disease and improve agriculture so that farm families can become self-sufficient, reducing hunger and poverty," said Dr. Trevor Mundel, president of the Global Health Program at the Bill & Melinda Gates Foundation. This partnership will be operationalized immediately, with the establishment of a management committee that will support identification and implementation of collaborations on global health and agricultural development projects.
About BGI
BGI was founded in 1999 with the mission of being a premier scientific partner to the global research community. The goal of BGI is to make leading-edge genomic science highly accessible through its investment in infrastructure that leverages the best available technology, economies of scale, and expert bioinformatics resources. BGI, which includes both private non-profit genomic research institutes and sequencing application commercial units, and its affiliates, BGI Americas, headquartered in Cambridge, MA, and BGI Europe, headquartered in Copenhagen, Denmark, have established partnerships and collaborations with leading academic and government research institutions as well as global biotechnology and pharmaceutical companies, supporting a variety of disease, agricultural, environmental, and related applications. BGI has established a proven track record of excellence, delivering results with high efficiency and accuracy for innovative, high-profile research which has generated over 250 publications in top-tier journals such as Nature and Science. These accomplishments include sequencing one percent of the human genome for the International Human Genome Project, contributing 10 percent to the International Human HapMap Project, carrying out research to combat SARS and German deadly E. coli, playing a key role in the Sino-British Chicken Genome Project, and completing the sequence of the rice genome, the silkworm genome, the first Asian diploid genome, the potato genome, and, most recently, have sequenced the human Gut metagenome, and a significant proportion of the genomes for 1,000 genomes. For more information about BGI please visit http://www.genomics.cn or http://www.bgiamericas.com.




The ex-Pfizer scientist who became an anti-vax hero
Reuters

URL: https://www.reuters.com/investigates/sp ... s-skeptic/
Category: Politics
Published: March 18, 2021

Description: Michael Yeadon was a scientific researcher and vice president at drugs giant Pfizer Inc. He co-founded a successful biotech. Then his career took an unexpected turn.



Late last year, a semi-retired British scientist co-authored a petition to Europe’s medicines regulator. The petitioners made a bold demand: Halt COVID-19 vaccine clinical trials. Even bolder was their argument for doing so: They speculated, without providing evidence, that the vaccines could cause infertility in women. The document appeared on a German website on Dec.1. Scientists denounced the theory. Regulators weren’t swayed, either: Weeks later, the European Medicines Agency approved the European Union’s first COVID-19 shot, co-developed by Pfizer Inc. But damage was already done. Social media quickly spread exaggerated claims that COVID-19 jabs cause female infertility. Within weeks, doctors and nurses in Britain began reporting that concerned women were asking them whether it was true, according to the Royal College of Obstetricians & Gynaecologists. In January, a survey by the Kaiser Family Foundation (KFF), a non-profit organization, found that 13% of unvaccinated people in the United States had heard that “COVID-19 vaccines have been shown to cause infertility.” What gave the debunked claim credibility was that one of the petition’s co-authors, Michael Yeadon, wasn’t just any scientist. The 60-year-old is a former vice president of Pfizer, where he spent 16 years as an allergy and respiratory researcher. He later co-founded a biotech firm that the Swiss drugmaker Novartis purchased for at least $325 million. In recent months, Yeadon (pronounced Yee-don) has emerged as an unlikely hero of the so-called anti-vaxxers, whose adherents question the safety of many vaccines, including for the coronavirus. The anti-vaxxer movement has amplified Yeadon’s skeptical views about COVID-19 vaccines and tests, government-mandated lockdowns and the arc of the pandemic. Yeadon has said he personally doesn’t oppose the use of all vaccines. But many health experts and government officials worry that opinions like his fuel vaccine hesitancy – a reluctance or refusal to be vaccinated – that could prolong the pandemic. COVID-19 has already killed more than 2.6 million people worldwide. “These claims are false, dangerous and deeply irresponsible,” said a spokesman for Britain’s Department of Health & Social Care, when asked about Yeadon’s views. “COVID-19 vaccines are the best way to protect people from coronavirus and will save thousands of lives.” Recent reports of blood clots and abnormal bleeding in a small number of recipients of AstraZeneca’s COVID-19 vaccine have cast doubt on that shot’s safety, leading several European countries to suspend its use. The developments are likely to fuel vaccine hesitancy further, although there is no evidence of a causative link between the AstraZeneca product and the affected patients’ conditions. Yeadon didn’t respond to requests for comment for this article. In reporting this story, Reuters reviewed thousands of his tweets over the past two years, along with other writings and statements. It also interviewed five people who know him, including four of his former colleagues at Pfizer. A Pfizer spokesman declined to comment on Yeadon and his stint with the company, beyond emphasizing that there is no evidence that its vaccine, which it developed with its German partner BioNTech, causes infertility in women. References to Yeadon’s petition appear on the website of a group founded by influential vaccine skeptic Robert F. Kennedy Jr., scion of the American political dynasty, who recently was banned on Instagram because of his COVID-19 vaccine posts. Syndicated writer and vaccine skeptic Michelle Malkin reported Yeadon’s concern about fertility in a column last month under the headline, “Pregnant Women: Beware of COVID Shots.” And a blog with an alarmist headline – “Head of Pfizer Research: Covid vaccine is female sterilization” – was shared thousands of times on Facebook. The visage and views of Yeadon, widely identified as an “Ex-VP of Pfizer,’’ can be seen on social media in languages including German, Portuguese, Danish and Czech. A Facebook post carries a video from November in which Yeadon claimed that the pandemic “fundamentally… is over.” The post has been viewed more than a million times. In October, Yeadon wrote a column for the United Kingdom’s Daily Mail newspaper that also appeared on MailOnline, one of the world’s most-visited news websites. It declared that deaths caused by COVID-19, which then totaled about 45,000 in Britain, will soon “fizzle out” and Britons “should immediately be allowed to resume normal life.” Since then, the disease has killed about another 80,000 people in the UK. Yeadon isn’t the only respected scientist to have challenged the scientific consensus on COVID-19 and expressed controversial views. Michael Levitt, a winner of the Nobel Prize for chemistry, told the Stanford Daily last summer that he expected the pandemic would end in the United States in 2020 and kill no more than 175,000 Americans – a third of the current total – and “when we come to look back, we’re going to say that wasn’t such a terrible disease.” And Luc Montagnier, another Nobel Prize winner, said last year that he believed the coronavirus was created in a Chinese lab. Many experts doubt that, but so far there is no way to prove or disprove it. Levitt told Reuters that his projections about the pandemic in the United States were wrong, but he still believes COVID-19 eventually won’t be seen as “a terrible disease” and that lockdowns “caused a great deal of collateral damage and may not have been needed.” Montagnier didn’t respond to a request for comment. What gives Yeadon particular credibility is the fact that he worked at Pfizer, says Imran Ahmed, chief executive of the Center for Countering Digital Hate, an organization that combats online misinformation. “Yeadon’s background gives his dangerous and harmful messages false credibility.” In a debate last fall in Britain’s House of Commons about the government’s response to the pandemic, parliamentarian Richard Drax called Yeadon an “eminent” scientist, and cited his view “that the virus is both manageable and nearing its end.” Drax didn’t respond to a request for comment. More recently, David Kurten, a member of the London Assembly – an elected body – tweeted there is a “real danger” that COVID-19 vaccines could leave women infertile. “The ‘cure’ must not be worse than the ‘disease’,” Kurten wrote. He, too, didn’t respond to a request for comment. Why Yeadon transformed from mainstream scientist to COVID-19 vaccine skeptic remains a mystery. Thousands of his tweets stretching back to the start of the pandemic document a dramatic shift in his views – early on, he supported a vaccine strategy. But they offer few clues to explain his radical turnabout. Some former colleagues at Pfizer say they no longer recognize the Mike Yeadon they once knew. They described him as a knowledgeable and intelligent man who always insisted on seeing evidence and generally avoided publicity. One of those ex-colleagues is Sterghios A. Moschos, who holds degrees in molecular biology and pharmaceutics. In December, Yeadon posted on Twitter a spoof sign that said, “DITCH THE MASK.” Moschos tweeted back: “Mike what hell ?! Are you out to actively kill people? You do realize that if you are wrong, your suggestions will result in deaths ??”
“It’ll all fade away”
Yeadon joined Twitter in October 2018 and soon became a prolific user of the platform. The thousands of his tweets reviewed by Reuters were provided by archive.org, which stores web pages, and FollowersAnalysis, a social media analytics company. When the coronavirus pandemic reached the UK in March 2020, Yeadon initially expressed support for developing a vaccine. He tweeted: “Covid 19 is not going away. Until we have a vaccine or herd immunity” – natural resistance resulting from prior exposure to the virus – “all that can be done is to slow its spread.” A week later he tweeted: “A vaccine might be along towards the end of 2021, if we’re really lucky.” When a fellow Twitter user said vaccines “harm many, many people,” Yeadon replied: “Ok, please refuse it, but do not impede its flow to neutrals or those keen to get it, thanks.” After Mathai Mammen, the global head of research & development for Janssen, the pharmaceutical division of Johnson & Johnson, posted on LinkedIn last summer that his company had started clinical trials of a vaccine, Yeadon responded: “Lovely to see this milestone, Mathai!” Mammen didn’t respond to a request for comment. But as early as April, Yeadon had begun voicing unorthodox views. While Britain was still in its first lockdown last spring, he declared: “there is nothing especially virulent or frightening about covid 19 … it’ll all fade away … Just a common & garden virus, to which the world overreacted.” And he predicted in a subsequent tweet that it was “unlikely” the death toll in the UK would reach 40,000. By September 2020, Yeadon’s statements were attracting attention beyond Twitter. At the time, a movement had emerged in Britain against lockdowns and other restrictions meant to curb the disease. He co-authored a lengthy article on a website called Lockdown Sceptics. It declared that the “pandemic as an event in the UK is essentially complete.” And, “There is no biological principle that leads us to expect a second wave.” Britain soon entered a much more deadly second wave. On Oct. 16, he wrote another lengthy article for the same website: “There is absolutely no need for vaccines to extinguish the pandemic. I’ve never heard such nonsense talked about vaccines. You do not vaccinate people who aren’t at risk from a disease.” In November, Yeadon appeared in a 32-minute video for the anti-lockdown group, Unlocked, sitting in a shed with a motorbike behind him. A shorter version appeared on Facebook titled, “The pandemic is over.” Yeadon called for an end to mass testing and claimed that 30% of the population was already immune to COVID-19 even before the pandemic started. By the time of the recording, he said, there was little scope for the virus to spread further in the UK because most people had already been infected or were immune. Those views ran counter to the findings of the World Health Organization. In December – nine months after declaring the COVID-19 outbreak a pandemic – the agency said testing suggested that less than 10% of the world’s population had shown evidence of infection. Yeadon’s petition to the European Medicines Agency to halt vaccine trials followed on Dec. 1. The agency didn’t respond to requests for comment for this article. It’s impossible to measure the impact of Yeadon’s claim that COVID-19 vaccines could cause female infertility. Anecdotally, though, many women have bought into it. Bonnie Jacobson, a waitress in Brooklyn, New York, can’t recall where she first heard about the fertility issue. But she told Reuters that it has made her hesitant to take a vaccine, as she’d like to have children “sooner than later.” “That’s my main concern,” she said. “Let more research come out.” After recently declining to get vaccinated, she said, the tavern where she worked fired her. Jacobson’s employer didn’t respond to a request for comment.
A good scientist
According to Yeadon’s LinkedIn profile, he joined Pfizer in 1995; the company had a large operation then in Sandwich in southern England. He rose to become a vice president and head of allergy and respiratory research. Many former colleagues say they are baffled by his transformation. Mark Treherne, chairman of Talisman Therapeutics in Cambridge, England, said he overlapped with Yeadon at Pfizer for about two years and sometimes had coffee with him. “He always seemed knowledgeable, intelligible, a good scientist. We were both trained as pharmacologists … so we had something in common.” “I obviously disagree with Mike and his recent views,” he said. Treherne’s company is researching brain inflammation, which he said could be triggered by coronaviruses. “This does not sound like the guy I knew 20 years ago.” Moschos, the ex-colleague who took issue with one of Yeadon’s tweets, said he considered him a mentor when they worked together at the drugmaker from 2008 to 2011. More recently, Moschos has been researching whether it’s possible to test for COVID-19 with breath samples. He said Yeadon’s views are “a huge disappointment.” He recounted hearing Yeadon in a radio interview last year. “There was a tone in his voice that was nothing like I ever remembered of Mike,” Moschos said. “It was very angry, very bitter.” John LaMattina, a former president of Pfizer Global Research and Development, also knew Yeadon. “His group was very successful and discovered a number of compounds that entered early clinical development,” LaMattina told Reuters in an email. He said Yeadon and his team were let go by Pfizer, however, when the company made the strategic decision to exit the therapeutic area they were researching. LaMattina said he had lost touch with Yeadon in recent years. Shown links to Yeadon’s video declaring the pandemic over and a copy of his petition to halt COVID-19 clinical trials, LaMattina replied: “This is all news to me and a bit of a shock. This seems out of character for the person I knew.”
“Chutzpah”
After losing his job at Pfizer in 2011, Yeadon set up a biotech company called Ziarco with three Pfizer colleagues. They wanted to continue researching promising therapies that targeted allergies and inflammatory diseases, ideas Pfizer had been developing but were at risk of being abandoned. Yeadon served as Ziarco’s chief executive. “I simply showed chutzpah and asked the senior-most people up the research line” at Pfizer to support the venture, Yeadon later recalled in an interview with Forbes. “And they said, ‘OK, assuming you raise private capital.’” In 2012, Ziarco announced it had initially secured funding from several investors, including Pfizer’s venture capital arm. Other investors later joined, including an Amgen Inc corporate venture capital fund. Amgen didn’t respond to a request for comment. “The intensity of effort took me away almost completely from my family and other interests for almost five years and you get only one life,” Yeadon told Forbes. On Twitter, Yeadon said he is married and has two adult daughters, and described a tough childhood – he said his mother committed suicide when he was 18 months old and his father, a doctor, abandoned him when he was 16. He said he was saved by a local social worker and adopted by a Jewish family whose “open handed love turned my life around.” While at Ziarco, Yeadon also worked as a consultant for several years at two Boston-area biotech companies, Apellis Pharmaceuticals and Pulmatrix Inc. Both firms said he no longer advises them. A spokeswoman for Apellis said, “His views do not reflect those of Apellis.” She didn’t elaborate. The hard work at Ziarco paid off. In January 2017, Novartis acquired the company for an upfront payment of $325 million, with the promise of $95 million more if certain milestones were met, according to Novartis’ 2017 annual report. Novartis was betting on the promise of a Ziarco drug, known as ZPL389, that had the potential to be a “first-in-class oral treatment for moderate-to-severe eczema,” a common and sometimes debilitating rash. Reuters wasn’t able to determine how much money Yeadon made from Novartis’ purchase of Ziarco. But in January 2020 he tweeted: “Oddly enough, I made millions from founding & growing a biotech company, creating many highly paid jobs, using my PhD & persuasion around the world.” Last July, Novartis disclosed it had discontinued the ZPL389 clinical development program and had taken a $485 million write down. A Novartis spokesman said the company decided to terminate the program after disappointing efficacy data in an early-stage clinical trial.
“I’ll soon be gone”
Earlier this year, a group of Yeadon’s former Pfizer colleagues expressed their concern in a private letter, according to a draft reviewed by Reuters. “We have become acutely aware of your views on COVID-19 over the last few months … the single mindedness, lack of scientific rigour and one sided interpretation of often poor quality data is far removed from the Mike Yeadon we so respected and enjoyed working with.” Noting his “vast following on social media” and that his claim about infertility “has spread globally,” the group wrote, “We are very worried that you are putting people’s health at risk.” Reuters couldn’t determine whether Yeadon received the letter. On Feb. 3, Yeadon’s Twitter account had a message for his 91,000 followers: “A tweet recently appeared under my ID, which was horribly offensive. As a result my account was locked. I of course deleted it. I want you to know of course that I didn’t write it.” A Twitter spokesman declined to comment. Yeadon didn’t make clear what tweet he was referring to. But shortly after, several Twitter users and a blog called Zelo Street posted screenshots of numerous offensive anti-Muslim tweets from Yeadon’s account from about a year ago. Many were captured at the time by archive.org. The next day, on Feb. 4, Yeadon cryptically mentioned in a tweet, “I’ll soon be gone.” Two days later, he was off Twitter. His followers were greeted with this message: “This account doesn’t exist.” His LinkedIn profile also soon changed, now stating that he is “Fully retired.” Clare Craig, a British pathologist, compared Yeadon’s treatment on Twitter – where some users derided his views as nonsense and dangerous – to medieval societies burning heretics at the stake. “There is no other way to see it than the burning of the witches,” said Craig, who has criticized lockdowns and COVID-19 tests. “Science is always a series of questions and the testing of those questions and when we are not allowed to ask those questions, then science is lost.” She said she spoke to Yeadon after he closed his Twitter account. “He will have a think about how he will contribute in the future,” she said.



Ukrainian servicewoman who died had shown no adverse reaction to COVID-19 vaccine: ministry
Reuters

URL: https://www.reuters.com/article/idUSKBN2BG12L
Category: healthNews
Published: March 24, 2021

Description: KYIV (Reuters) - A Ukrainian servicewoman who died two days after taking the AstraZeneca CoviShield vaccine had not complained of any ill effects after taking the shot, a statement on the health ministry’s website said on Wednesday.

no-symptoms.jpg
NO SYMPTOMS!

The statement urged the public not to jump to conclusions about the death, which is still being investigated, and said the woman had chronic cardiovascular disease and other comorbidities. Nine other people were given the vaccine from the same batch on the same day and had no ill effects, it said.



Hong Kong halts BioNTech COVID-19 vaccines, investigates packaging
Reuters

URL: https://www.reuters.com/business/health ... 021-03-24/
Category: healthNews
Published: March 24, 2021

Description: Hong Kong authorities halted the use of a COVID-19 vaccine developed by Germany's BioNTech on Wednesday, citing defective packaging, in a move that triggered scenes of confusion in inoculation centres across the city. The suspension comes as the Asian financial hub has faced a sluggish take-up of vaccines due to dwindling confidence in China's Sinovac vaccine and fears of adverse reactions. Inoculation centre staff turned away people booked to take the BioNTech vaccine, with many Hong Kong-ers unsure as to the reason and asking for explanations. Adding to the confusion, local media reports said one doctor was reprimanded for promoting the BioNTech vaccine over Sinovac's.



"As a precautionary measure BioNTech requested the suspension" for its vaccines in Hong Kong until an investigation is complete, the city's Director of Health, Constance Chan, told a news conference. The city started vaccinating residents with doses from Sinovac in February and began offering the one developed by BioNTech in March. The BioNTech vaccine is distributed in Hong Kong and Macau via a partnership with China's Fosun Pharma, while BioNTech partners with Pfizer in markets outside greater China. The BioNTech vaccine has shown greater take-up since its launch. Over the past week, more than double the number of people have booked the BioNTech shot compared to Sinovac, according to government figures. Chan said the government had initially contacted Fosun Industrial (Hong Kong), the distributor, after it found some cases of cracks in vaccine containers and stains on some bottles. She said Fosun replied on Wednesday morning stating that it needed to further investigate and would suspend vaccination until further notice. "BioNTech and Fosun have not found any reason to believe that product safety is at risk," she said. Fosun's parent company, Shanghai Fosun Pharmaceutical, said in a filing on Wednesday it was investigating with BioNTech. BioNTech said in a statement that no other batches to other regions were affected and it was investigating the root cause. Macau said on Wednesday it was also suspending the BioNTech vaccine due to the packaging flaw. Officials said Sinovac vaccinations would continue to take place as scheduled.
WAIT AND SEE
In a separate incident, Hong Kong's government said it shut a private clinic that administered COVID-19 vaccines after a physician, named Dr Lau, "violated an agreement" under the city's inoculation programme. Broadcaster RTHK reported that Lau recommended people take the BioNTech shot, rather than Sinovac's, due to its better international reputation. Lau did not immediately respond to requests for comment. His clinic had been providing Sinovac vaccines and not the BioNTech ones, which are only available at larger public sector facilities. Distrust of the mainland has intensified among residents in recent years with months of anti-government and anti-China protests driven by a perception that Beijing is pushing the semi-autonomous city onto a more authoritarian path. Media reports of several deaths after vaccinations have also kept some people jittery even though the government has said there was no direct link. With low levels of infection in the city, many people are opting to wait and see before getting a shot. Only about 5% of Hong Kong's 7.5 million residents have been vaccinated, and more than one third of them received the BioNTech shot. For one 67-year-old resident, who gave his surname as Lau, there was no question as to which vaccine he was going for on Tuesday - the BioNTech one. "It has better data, there are more people getting it internationally," he said. "The other one, the data is not clear." City leader Carrie Lam has repeated called for people to get vaccinated. "When many places all over the world are scrambling for vaccines, we have a pretty assured supply," she said on Tuesday.



Hong Kong government to delay imports of AstraZeneca vaccine amid safety concerns
Reuters

URL: https://www.reuters.com/article/idUSKBN2BW0C4
Category: healthNews
Published: April 9, 2021

Description: HONG KONG (Reuters) - Hong Kong said on Friday it will delay shipments of AstraZeneca’s COVID-19 vaccine this year amid mounting concerns over possible links between the shot and very rare cases of blood clots. The Chinese-ruled city had ordered 7.5 million doses from the British-Swedish company, which were scheduled to arrive in the second half of 2021. Health Secretary Sophia Chan said the global financial centre had a sufficient supply of vaccines, with a total of 15 million doses of Germany’s BioNTech and China’s Sinovac - the only two vaccines available in the city. “Even if we have signed a pre-purchase agreement with AstraZeneca, we believe that AstraZeneca vaccines will not need to be supplied to Hong Kong this year, so as not to cause a waste when the vaccine is still in short supply globally,” Chan said. The government was considering buying a new type of vaccine that may offer better protection, she added. More than 700,000 COVID-19 vaccine doses have been administered to the city’s 7.5 million population so far, a figure Hong Kong leader Carrie Lam said was unsatisfactory.

carrie-lam.jpg

The sluggish take-up comes amid dwindling confidence in the Sinovac vaccine and fears of adverse reactions, while BioNTech vaccines were temporarily halted due to packaging defects. Earlier on Friday, Australian Prime Minister Scott Morrison said his country doubled its order of the Pfizer Inc COVID-19 vaccine. Until late Thursday, Australia based its vaccination programme largely on AstraZeneca. The Philippines and South Korea have suspended the use of AstraZeneca shots for people under age 60. Italy on Wednesday joined France, the Netherlands, Germany and others in recommending a minimum age for recipients of AstraZeneca’s shot, and Britain said people under 30 should get an alternative. Indonesian Health Minister Budi Gunadi Sadikin said on Thursday the country was in talks with China on getting as many as 100 million COVID-19 vaccine doses to plug a gap in deliveries caused by delays in the arrival of AstraZeneca shots. European and British regulators said on Wednesday they had found possible links between AstraZeneca’s vaccine and very rare cases of blood clots, but reaffirmed the vaccine’s importance in protecting people against COVID-19. Hong Kong has registered more than 11,500 coronavirus cases, with 205 deaths.



South African variant can 'break through' Pfizer vaccine, Israeli study says
Reuters

URL: https://www.reuters.com/article/us-heal ... SKBN2BX0JZ
Category: healthNews
Published: April 10, 2021

Description: JERUSALEM (Reuters) - The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.

netanyahu-gates.jpg
We'll call it a "breakthrough" and blame the Mandela effect.

The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit. But among patients who had received two doses of the vaccine, the variant’s prevalence rate was eight times higher than those unvaccinated - 5.4% versus 0.7%. This suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain that has come to comprise nearly all COVID-19 cases in Israel, the researchers said. “We found a disproportionately higher rate of the South African variant among people vaccinated with a second dose, compared to the unvaccinated group. This means that the South African variant is able, to some extent, to break through the vaccine’s protection,” said Tel Aviv University’s Adi Stern. The researchers cautioned, though, that the study only had a small sample size of people infected with the South African variant because of its rarity in Israel. They also said the research was not intended to deduce overall vaccine effectiveness against any variant, since it only looked at people who had already tested positive for COVID-19, not at overall infection rates. Pfizer and BioNTech could not be immediately reached for comment outside business hours. The companies said on April 1 that their vaccine was around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. In respect to the South African variant, they said that among a group of 800 study volunteers in South Africa, where B.1.351 is widespread, there were nine cases of COVID-19, all of which occurred among participants who got the placebo. Of those nine cases, six were among individuals infected with the South African variant. Some previous studies have indicated that the Pfizer/BioNTech shot was less potent against the B.1.351 variant than against other variants of the coronavirus, but still offered a robust defence. While the results of the study may cause concern, the low prevalence of the South African strain was encouraging, according to Stern. “Even if the South African variant does break through the vaccine’s protection, it has not spread widely through the population,” said Stern, adding that the British variant may be “blocking” the spread of the South African strain. Almost 53% of Israel’s 9.3 million population has received both Pfizer doses. Israel has largely reopened its economy in recent weeks while the pandemic appears to be receding, with infection rates, severe illness and hospitalizations dropping sharply. About a third of Israelis are below the age of 16, which means they are still not eligible for the shot.



U.S. calls for pause on Johnson & Johnson's COVID-19 vaccine
Reuters

URL: https://www.reuters.com/article/us-heal ... SKBN2C01BC
Category: healthNews
Published: April 13, 2021

Description: (Reuters) -U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s single-dose COVID-19 vaccine after six recipients developed a rare disorder involving blood clots. The U.S. Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday to review the cases. All the six recipients were women between the ages of 18 and 48. One woman died and a second in Nebraska has been hospitalized in critical condition, the New York Times reported, citing officials. The CDC and the U.S. Food and Drug Administration said in a joint statement that the adverse events appear to be extremely rare right now. As of April 12, more than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the United States. The company’s shares were down 3% before the opening bell. The move from the U.S. regulators comes less than a week after Europe’s drugs regulator said it was reviewing rare blood clots in four people in the United States who received the shot.



Media stating six blood clots have been reported causing concern? I guess 54 recorded deaths in VAERS is within normal limits or what's expected and therefore no reason for concern?




Canada has second case of rare blood clots after AstraZeneca vaccine
Reuters

URL: https://www.reuters.com/world/americas/ ... 021-04-17/
Category: healthNews
Published: April 17, 2021

Description: Canada on Saturday reported a second case of rare blood clots with low platelets after immunization with AstraZeneca's (AZN.L) COVID-19 vaccine in a week, while it said it still recommended the use of the shot. The person who experienced the very rare event has been treated and is recovering, Canada's health ministry said in a statement, adding that the person lives in the province of Alberta. Based on the evidence available, Canada still maintains that the benefits of the AstraZeneca vaccine outweigh the potential risks, the statement said.

trudeau-turban.jpg

Canada health authorities "will continue to monitor the use of all COVID-19 vaccines closely and examine and assess any new safety concerns," the statement said. Canada reported a first blood clotting associated with the vaccine on Tuesday, and a day later, after a review, health authorities said they would not restrict use of the AstraZeneca vaccine. A separate advisory council had earlier recommended Canada stop offering the vaccine to people under 55. That panel is in the process of reviewing its advice. Canada has been ramping up its vaccination campaign, but still has a smaller percentage of its population inoculated than dozens of other countries, including the United States and Britain. Amid a spiking third wave of infections, Ontario, Canada's most populous province, announced new public health restrictions on Friday, including closing the provinces borders to domestic travelers.



European Medicines Agency: More than 300 cases of rare blood clot events worldwide
Reuters

URL: https://www.reuters.com/business/health ... 021-04-20/
Category: healthNews
Published: April 20, 2021

Description: The European Union’s drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.

inigo-montoya.jpg
My name is Inigo Montoya. You have a rare blood clot. Prepare to die.

There were 287 occurrences with the AstraZeneca vaccine, eight with Johnson & Johnson’s shot, 25 for Pfizer and five for Moderna, said Peter Arlett, Head of Data Analytics at the European Medicines Agency (EMA).



Israel examining heart inflammation cases in people who received Pfizer COVID shot
Reuters

URL: https://www.reuters.com/world/middle-ea ... 021-04-25/
Category: healthNews
Published: April 25, 2021

Description: Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer’s COVID-19 vaccine, though it has not yet drawn any conclusions. Pfizer said it has not observed a higher rate of the condition than would normally be expected in the general population.

nachman-ash.jpg
Pay no attention to the man behind the curtain.

Israel's pandemic response coordinator, Nachman Ash, said that a preliminary study showed "tens of incidents" of myocarditis occurring among more than 5 million vaccinated people, primarily after the second dose. Ash said it was unclear whether this was unusually high and whether it was connected to the vaccine. Most of the cases were reported among people up to age 30. "The Health Ministry is currently examining whether there is an excess in morbidity (disease rate) and whether it can be attributed to the vaccines," Ash said. Ash, who spoke about the issue in a radio interview and during a news conference, referred to it as a "question mark", and emphasized that the Health Ministry has yet to draw any conclusions. Determining a link, he said, would be difficult because myocarditis, a condition that often goes away without complications, can be caused by a variety of viruses and a similar number of cases were reported in previous years. Pfizer, asked by Reuters about the review, said it is in regular contact with Israel’s Health Ministry to review data on its vaccine. The company said it "is aware of the Israeli observations of myocarditis that occurred predominantly in a population of young men who received the Pfizer-BioNTech COVID-19 vaccine". "Adverse events are regularly and thoroughly reviewed and we have not observed a higher rate of myocarditis than what would be expected in the general population. A causal link to the vaccine has not been established," the company said. "There is no evidence at this time to conclude that myocarditis is a risk associated with the use of Pfizer/BNT COVID-19 vaccine." Israel has been a world leader in its vaccination rollout, with close to 60% of its 9.3 million population having received the Pfizer vaccine. Its nationwide database has already showed the vaccine to be highly effective in preventing the symptoms and severe illness associated with COVID-19. Since January, shortly after the vaccine campaign began, daily infections dropped from a peak of more than 10,000 to just 129 before the weekend. Nadav Davidovitch, director of the school of public health at Israel's Ben Gurion University, said that even if a correlation between the myocarditis cases and the vaccine were established, it did not appear to be serious enough to stop administering the vaccine. "It's a situation that should be looked into, and we need to wait for a final report, but in an interim analysis it seems the risk of getting sick from COVID-19 is much higher than from the vaccine's adverse events, and the risk of peri/myo-carditis following the vaccine is low and temporary," he said.
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

An outbreak in a Los Barrios residence causes 46 deaths from coronavirus

Postby smix » Tue Feb 16, 2021 2:18 pm

An outbreak in a Los Barrios residence causes 46 deaths from coronavirus
ABC Andalucia Cadiz

URL: https://sevilla.abc.es/andalucia/cadiz/ ... ticia.html
Category: healthNews
Published: February 4, 2021

Description: Translated from Spanish
* The Junta de Andalucía has intervened in the center and has interrupted the inoculation of the second dose of the vaccine

our-lady-of-the-rosary-los-barios.jpg

Covid-19 does not give truce. The start of the vaccination campaign in nursing homes is not preventing a trail of deaths. In Los Barrios (Cádiz) they know it well. Unfortunately, the Nuestra Señora del Rosario residence yesterday added 46 deaths from Covid-19 among its users due to an outbreak registered in January, according to data provided by the Andalusian Health Service (SAS). At the beginning of the year, residents and workers were vaccinated with the first dose of Pfizer, although the inoculation of the second has had to be interrupted given the incidence of the pandemic. The situation is so serious that the medicalization of the Andalusian Government of this private nursing home a few weeks ago has not been enough and the Ministry of Health has had to intervene in this center. An inspection of the health services determined that it was a necessary measure "in view of the imminent risk to public health, and in particular for the users and workers of this center, as the current protocol for disinfection and isolation of positive cases cannot be guaranteed ". This Wednesday, the situation remained extremely complicated in this residence. As explained by the provincial secretary of the FSP of the UGT, José Porras Naranjo, there were 28 residents and 12 workers, including the director, with Covid-19. Currently, this nursing home has 94 users, although its capacity is 145. FSP de UGT ensures that the residence is not "fully" medicalized and that the disinfection is being carried out by the firefighters. This union representative reiterates his criticism of the management in this center, since he insisted that the outbreak was detected on January 12, that on January 18 the UGT warned that eight older people had died and that on the 28th 30 had already died. " We are already at 46 deaths. Where is this medicalization and intervention? Where is the stabilization of the situation to which the territorial delegate referred a few days ago? In this residence they have acted late and badly. Los Barrios is not an isolated case. In a nursing home in Sancti Petri , in Chiclana, 22 elderly people have already died from an outbreak that has also infected 79 residents and 24 workers in recent weeks.
Reopens non-essential activity to the Neighborhoods
Precisely this Wednesday, the Board has lifted the closure of non-essential activity in Los Barrios after two weeks, with the incidence rate standing at 799 cases per 100,000 inhabitants. Very close, in Gibraltar , which this Wednesday only registered 13 new cases, the vaccination campaign continues to advance despite having already registered 79 deaths from Covid-19. Yesterday 13,071 people had been vaccinated with the first dose and 2,320 with the second, some of them Spanish who work in the social and health sector. The Government of El Peñón, which reopened its non-essential activity on Monday except for the hotel industry and schools after a month of harsh restrictions, has also included young people between 16 and 18 years old in the priority groups for vaccination.

Cesare Sacchetti - March 1, 2021

tragedia-absoluta.jpg

In Spagna, 930 persone nelle case di cura sono morte dopo aver ricevuto il vaccino Covid. In Germania, in un'altra casa di cura, 8 persone su 31 sono morte dopo aver ricevuto il vaccino. In Scozia, sempre nelle case di cura, 619 persone sono morte dopo aver ricevuto il vaccino Covid. È vero. C'è la "pandemia", ma non è il virus che l'ha causata. È il vaccino.

Translated from Italian: In Spain, 930 people in nursing homes have died after receiving the Covid vaccine. In Germany, in another nursing home, 8 out of 31 people died after receiving the vaccine. In Scotland, also in nursing homes, 619 people died after receiving the Covid vaccine. It's true. There is the "pandemic", but it is not the virus that caused it. It's the vaccine.

https://www.eldiestro.es/2021/02/traged ... ntagiadas/

PDF: Victimas de los politicos
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

4,500 people diagnosed with COVID after getting 1st vaccine dose

Postby smix » Tue Feb 16, 2021 3:27 pm

4,500 people diagnosed with COVID after getting 1st vaccine dose
Israel National News

URL: https://www.israelnationalnews.com/News ... spx/294794
Category: healthNews
Published: January 12, 2021

Description: Health Ministry official warns one vaccine dose is not enough to prevent COVID-19 infection as morbidity continues to rise.
The head of the public health services at the Health Ministry, Dr. Sharon Elrai-Price, warned Tuesday during a briefing that a single dose of the coronavirus vaccine does not provide sufficient protection against infection from the virus. Dr. Elrai-Price noted that 17% of the severely ill patients who are currently hospitalized are patients who received a first dose of the vaccine before their hospitalization. The data show that to date, 4,500 people have been diagnosed with the coronavirus after having received the first vaccine dose, of whom 375 have been hospitalized due to the disease. Of those hospitalized, 244 were hospitalized in the first week after their vaccination. 124 in the second week and seven more than 15 days from when they received the vaccine. "The number of verified cases has reached a new high, we have passed the point of 9,000 positive tests. There has never been such a figure," said Dr. Elrai-Price. "The British mutation is spreading in the community, not just in people who have returned from England. There is no doubt that part of the increase in morbidity is due to the mutation," Elrai-Price added, clarifying that the morbidity rates would not be brought down quickly. Both the Pfizer and Moderna coronavirus vaccines require two doses to reach their full level of effectiveness.





This is not a vaccine
Israel National News

URL: https://www.israelnationalnews.com/News ... spx/294852
Category: healthNews
Published: January 13, 2021

Description: The Israeli people haven't been given information required for a sufficient risk-benefit analysis in this extraordinary endeavor. Opinion



The nation of Israel is at this moment engaged in a historic and decisive juncture that will determine the trajectory of this people now and for the foreseeable future. It is an undertaking that cannot be overstated. As is now widely publicized, revealed initially by former PM Ehud Barak and then Prime Minister Benjamin Netanyahu himself, a deal has been made. In Israel, Pfizer has found a home for its experimental pilot program of expansive human trials. According to Barak, Pfizer has chosen our country for its decades of meticulously recorded medical and vaccination records, which allow it to explain adverse reactions to its product by pointing to previously existing conditions within the patient. In effect, Bibi has signed up his people, all seven million citizens aged 12 years and over, without our informed consent, to become the first country in its entirety to do human testing on a technology which has been, for many decades, attempted and failed in the laboratory. Thus far, the pilot study is moving at truly astonishing speed; some two million people have already been injected under a program that runs daily from early morning until late night, even on Shabbat. However, the Israeli people have not been given the information required to make a sufficient risk benefit analysis in this extraordinary endeavor. In fact, they have been given little information at all and that includes complete opacity of data on the unfolding outcomes of adverse reactions currently taking place. Our citizens must first and foremost define the discussion in order to accurately weigh their choices. What they are being asked to inject is not a vaccine as defined by the CDC as “A product that stimulates a person’s immune system to produce immunity to a specific disease.” Rather, it is an experimental and novel technology. By definition of the FDA as a component used as treatment to affect a body’s function, it is in fact a medical device, a physical device that comes in a molecular sized package. Erroneously referring to this intervention as a vaccine exploits the public's ingrained trust of the vaccination program to solicit knee jerk response and action. It keeps us entrenched in needless debate in place of taking the necessary measures to investigate the impact on our health. DNA is, in short, the basis for our genetic structure. Inside each cell are codes which transfer its information to make proteins through messenger RNA. Messenger RNA is an intermediary between gene and protein and the protein elicits the immune response, not the RNA. The contents of this shot being given on an experimental basis is a synthetic messenger RNA that is inserted into the human system to activate the cell to manufacture, in this case, a spike protein. An mRNA vaccine is not a vaccine, because it does not elicit an immune response. What it is, is genetic engineering. There are a number of prominent concerns of serious adverse reactions of which include, in brief summary, some of the following: In previous clinical trials since the 1960’s attempts to vaccinate against RSV, Dengue, SARS and MERS, the studies each failed during the animal phase. Cats, ferrets, monkeys, and rabbits each and every time experienced Antibody Dependent Enhancement (ADE), also known as pathogenic priming or a cytokine storm. This occurs when the immune system creates an uncontrolled and overwhelming inflammatory response upon being confronted with the pathogen in the real world, and the outcome, tragically, is death. The same immune system overreaction took place in a number of infants in clinical trials who received an attempted RSV shot, as well as some six hundred Filipino children who died following early vaccination against Dengue and it remains a viable concern today. Autoimmune disease occurs when the body's immune system can't tell the difference between its own cells and foreign cells, and causes the body to attack its normal cells. It has been suggested that "molecular mimicry" may contribute to this problem, with antibodies to SARS-CoV-2 cross-reacting with structurally similar host protein sequences and raising an acute autoimmune response against them. Scientists have determined that the same spike protein found in SARS viruses are also responsible for the development of the placenta in mammals, including humans, and is therefore an essential prerequisite for a successful pregnancy. If a woman’s body is primed to attack these protein spikes, the immune system may prevent a placenta from being formed, which would render that woman infertile. Drs Yeadon and Wodarg further explain; “To my knowledge, Pfizer/BioNTech has yet to release any samples of written materials provided to patients, so it is unclear what, if any, information regarding (potential) fertility-specific risks caused by antibodies is included. According to section 10.4.2 of the Pfizer/BioNTech trial protocol, a woman of childbearing potential is eligible to participate if she is not pregnant or breastfeeding, and is using an acceptable contraceptive method as described in the trial protocol during the intervention period (for a minimum of 28 days after the last dose of study intervention). This means that it could take a relatively long time before a noticeable number of cases of post vaccination infertility could be observed.” We have additionally heard the reports of multiple cases of Bell's Palsy in both trials and administration, numerous cases of anaphylaxis shock even when no previous allergies were detected, as well as several announced incidents of “false positive” HIV tests. The remaining elephant in the room is that of the greatest unknown, of tampering with the human genome. There is much we have yet to comprehend of the complexity of the human body and immune system. Science has gotten it wrong many times before, having made assumptions about its ability to exert its dominance over nature. It is still and always nature which has the final say. In the human genome project they tried genetic engineering by changing a singular gene which they believed was the defect in the genetic process. Unexpectedly, instead of correcting, it caused a domino effect of uncontrolled regulation onto multiple other genes. Of the media press release of 95% efficacy taken as gospel and repeated as fact, Peter Doshi of the British Medical Journal posits whether the study trials were designed too poorly not to fail. With 3,410 total cases of suspected, but unconfirmed COVID 19 in the overall study population accounted for makes a relative risk reduction of 19%, far below the 50% required for emergency use authorization. Pfiizer, Moderna, Dr Anthony Fauci and Dr Soumya Swaminathan, the WHO’s chief scientist, have made it abundantly clear that the novel mRNA strand entering the cell is not intended to stop transmission but rather as a treatment. However, were we at long last permitted to hold public discourse on the profoundly viable and formerly ubiquitous treatments such as Ivermectin, for one example, and were these treatments not denied us both in access and scientific data but disseminated to the global community, we might not have had need for an emergency use technology at all. If this experiment does prove to cause any or combination of these problems in a year’s time or a few more and has already been administered to billions worldwide it will be too late. It cannot be removed and it cannot be turned off, it has been irretrievably unleashed into the cellular system. And there is not a government in the world nor the manufacturer himself who will be held accountable if you find yourself come to grave harm. In a multitude of monumental changes that have taken place over the course of the last year the one thing that has remained consistent is that the mortal risk a Covid-19 infection poses is, with exception, to those above 65 years or with comorbidity. There is not in existence a reasonable scientific or medical indication to inject an experimental technology forever into the veins of anyone outside that narrow group. I argue that to do so it is a reckless and cynical display of disregard for human life and well being in the perverted name of saving a particular few. We claim an unbridled love of science and yet we are missing the crater sized gaps in reason. A tremendous risk of known and “known unknown” issues is considered against the singular benefit to avert symptoms in questionable potential at best. Tested on an uninformed populace, this is not a flag for public health. The use of the word “vaccine” and the magic bullet it has come to represent confounds the discussion as does its expeditious administration alongside an exponentially changing world. The brevity with which this technology was so recently produced is long forgotten and I, with many others, face the sobering fact that with a now live totalitarian Green Passport initiative, must choose which of my freedoms to concede, the loss of my self determination or my autonomy of body itself. I stand for your right to understand the risks and choose to take this intervention. I ask you to stand, equally and emphatically, with my right to understand them and choose not to. However forcefully you may disagree with my perspectives, the risks of my being wrong don't touch the risks of removing the freedoms to choose them. Free choice is what breathes living into life. It is what gives us the opportunity to learn. It is what gives us hope for the future. These are the greatest challenges we will ever meet. Whatever you are called to do to make change, do it soon, do it now. Your choice matters.
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

Immunologist: Pfizer, Moderna Vaccines Could Cause Long-Term Chronic Illness

Postby smix » Tue Feb 16, 2021 3:54 pm

Immunologist: Pfizer, Moderna Vaccines Could Cause Long-Term Chronic Illness
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... c-illness/
Category: healthNews
Published: February 9, 2021

Description: In new research published in Microbiology & Infectious Diseases, immunologist J. Bart Classen warns the mRNA technology used in the Pfizer and Moderna COVID vaccines could create “new potential mechanisms” of adverse events that may take years to come to light.
Back in 1999, leading U.S. Food and Drug Administration (FDA) official Dr. Peter Patriarca contended that modern advances in vaccine technology were rapidly “outpacing researchers’ ability to predict potential vaccine-related adverse events.” Patriarca mused that this could lead to “a situation of unforeseen and unpredictable vaccine outcomes.” In a new research article published in Microbiology & Infectious Diseases, veteran immunologist J. Bart Classen expresses similar concerns and writes that “RNA-based COVID vaccines have the potential to cause more disease than the epidemic of COVID-19.” For decades, Classen has published papers exploring how vaccination can give rise to chronic conditions such as Type 1 and Type 2 diabetes — not right away, but three or four years down the road. In this latest paper, Classen warns that the RNA-based vaccine technology could create “new potential mechanisms” of vaccine adverse events that may take years to come to light. Classen’s study establishes the potential for the messenger RNA (mRNA) vaccines developed by Pfizer and Moderna to activate human proteins to take on “pathologic configurations” — configurations associated with chronic degenerative neurological diseases. Although his specific interest is in prion diseases (conditions associated with misfolded versions of normal proteins), Classen also outlines a handful of other mechanisms whereby RNA-based vaccines could give rise to “multiple other potential fatal adverse events.” Ensuring that patients clearly understand risks — including known risks as well as potential unknown risks — is an important component of the informed consent process. This is all the more true when the intervention is experimental and lacks long-term safety data, as is the case with the Pfizer and Moderna vaccines against COVID-19. The FDA authorized the two vaccines for widespread emergency use based on just two months of clinical trial data. Unfortunately, it is not unusual for researchers’ communication of risks to be perfunctory. In October, researchers at New York University and Tulane reported that the information communicated to participants in the coronavirus clinical trials about a worrisome problem known as pathogenic priming was “sufficiently obscured” as to make “adequate patient comprehension” of risks “unlikely.” It would be interesting to know what those researchers would say about Classen’s blunt conclusion that “Approving a vaccine, utilizing novel RNA technology without extensive testing is extremely dangerous.” Those contemplating COVID injections may be ignoring potential risks at their own peril.
--
PDF: COVID-19 RNA Based Vaccines and the Risk of Prion Disease

ABSTRACT
Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS-CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing. In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine recipients. The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations. The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified. Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme. This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases. The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit.
DISCUSSION EXCERPT:
There are many other potential adverse events that can be induced by the novel RNA based vaccines against COVID-19. The vaccine places a novel molecule, spike protein, in/on the surface of host cells. This spike protein is a potential receptor for another possibly novel infectious agent. If those who argue that the COVID-19 is actually a bioweapon are correct, then a second potentially more dangerous virus may be released that binds spike protein found on the host cells of vaccine recipients




Could Spike Protein in Moderna, Pfizer Vaccines Cause Blood Clots, Brain Inflammation and Heart Attacks?
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... ain-heart/
Category: healthNews
Published: February 10, 2021

Description: Dr. J. Patrick Whelan, a pediatric rheumatologist, warned the FDA in December that mRNA vaccines could cause microvascular injury to the brain, heart, liver and kidneys in ways not assessed in safety trials.
On Dec. 8, 2020, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) received a public submission from J. Patrick Whelan, M.D., Ph.D. The submission was in response to the agency’s request for comments regarding vaccines against SARS-CoV-2 in advance of the Dec. 10 meeting when the committee would review the Pfizer/BioNTech (BNT162b2) SARS-CoV-2 vaccine for emergency use authorization (EUA). Whelan’s training (at Harvard, Texas Children’s Hospital and Baylor College of Medicine) includes degrees in biochemistry, medicine and rheumatology. For 20 years, he worked as a pediatric rheumatologist. He currently specializes in treating children with multisystem inflammatory syndrome (MIS-C), which has been associated with coronavirus infections. In his public submission, Whelan sought to alert the FDA about the potential for vaccines designed to create immunity to the SARS-CoV-2 spike protein to instead cause injuries. Specifically, Whelan was concerned that the new mRNA vaccine technology utilized by Pfizer and Moderna has “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.” While Whelan did not dispute the vaccines’ potential to quickly arrest the spread of the virus (assuming that the vaccines prove to actually prevent transmission — also not assessed in the clinical trials), he cautioned that “it would be vastly worse if hundreds of millions of people were to suffer long-lasting or even permanent damage to their brain or heart microvasculature as a result of failing to appreciate in the short-term an unintended effect of full-length spike protein-based vaccines on other organs.” Unfortunately, Whelan’s concerns were not acknowledged, and the agency instead relied on the limited clinical trial data. The VRBPAC endorsed the use of the Pfizer vaccine on Dec. 10. The following day, the FDA issued the first COVID-19 vaccine emergency use authorization allowing the Pfizer-BioNTech COVID-19 vaccine to be widely distributed in individuals 16 and older without calling for the additional studies that Whelan felt were critical to assure safety of the vaccine, especially in children. Why was Whelan worried about the mRNA vaccines causing blood clots and inflammation? One of the peculiar and often deadly findings with regard to SARS-CoV-2 infection is widespread damage occurring in numerous organs beyond the lungs. Clinicians around the world have seen evidence that suggests the virus may cause heart inflammation, acute kidney disease, neurological malfunction, blood clots, intestinal damage and liver problems. Unexpectedly, however, clinicians observe a very limited or non-existent presence of the virus in organs other than the lungs. Here is what we currently know about the impact of the virus outside the lungs.
Cardiovascular complications from COVID-19
Though COVID-19 was originally thought to be a respiratory infection, it’s since become clear the infection threatens the heart, too. Dr. Aeshita Dwivedi, a cardiologist at Lenox Hill Hospital in New York City has stated: “As the COVID-19 pandemic has evolved, research has progressively demonstrated this virus’s impact on multiple organs of the body including the heart.” It has been reported that nearly a quarter of people hospitalized with COVID-19 experience myocardial injury and many develop arrhythmias or thromboembolic disease. In a prospective study that followed 100 patients who recovered from COVID-19, the investigators found involvement of the heart on MRI scans in 78% of patients, and ongoing myocardial inflammation in 60%. These findings were independent of the severity of the infection, overall course of the illness and time from the original diagnosis. In October 2020, researchers took a more detailed look at the heart after death from COVID-19 and found “cardiac damage was common, but more from clotting than inflammation” and that “microthrombi (small blot clots) were frequent.” “We did not expect this,” said study co-author Dr. Renu Virmani, of CVPath Institute in Gaithersburg, Maryland. “It seems to be unlikely that the direct viral invasion of the heart is playing a major role in making myocardial necrosis and microthrombi.” Dr. Hyung Chun, a Yale cardiologist, suggests that the endothelial cells lining the blood vessels potentially release inflammatory cytokines that further exacerbate the body’s inflammatory response and lead to the formation of blood clots. Chun has stated: “The ‘inflamed’ endothelium likely contributes not only to worsening outcome in COVID-19, but also is considered to be an important factor contributing to risk of heart attacks and strokes.” A subsequent study published last month confirmed the findings of microthrombi resulting in myocyte necrosis, indicative of a recent myocardial infarction (heart attack), in 40 individuals who died from COVID-19 infection — the studies also identified microthrombi as a major cause of cardiac injury.
Neurological complications of COVID
Individuals with COVID-19 experience a vast number of neurological symptoms, such as headaches, ataxia, impaired consciousness, hallucinations, stroke and cerebral hemorrhage. But autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms. In a study of 18 COVID-19 patients with neurological symptoms who died in hospitals last April, Mukerji and colleagues found very low levels of viral RNA — the source of which is a mystery — in only five of the patient brains. Because the low RNA concentration “seems out of proportion to the profound deficits that people are experiencing,” Mukerji said, “I’d be extremely surprised [if] the majority of cases where people are having neurological symptoms are due to direct viral invasion.” In a more recent analysis published Feb. 4, 2021, in the New England Journal of Medicine, researchers from the National Institute of Neurological Disorders and Stroke documented microvascular injury but no evidence of virus in the brains of patients who died from COVID-19. They reported, “In a convenience sample of patients who had died from COVID-19, multifocal microvascular injury was observed in the brain and olfactory bulbs by means of magnetic resonance microscopy, histopathological evaluation and immunohistochemical analysis of corresponding sections, without evidence of viral infection.” If not viral infection, what else could be causing injury to distant organs associated with COVID-19? The most likely culprit that has been identified is the COVID-19 spike protein released from the outer shell of the virus into circulation. Research cited below has documented that the viral spike protein is able to initiate a cascade of events that triggers damage to distant organs in COVID-19 patients. Worryingly, several studies have found that the spike proteins alone have the capacity to cause widespread injury throughout the body, without any evidence of virus. What makes this finding so disturbing is that the COVID-19 mRNA vaccines manufactured by Moderna and Pfizer and currently being administered throughout the U.S. program our cells to manufacture this same coronavirus spike protein as a way to trigger our bodies to produce antibodies to the virus. According to Whelan’s letter to the FDA, the “Pfizer/BioNTech vaccine is composed of an mRNA that produces a membrane-anchored full-length spike protein.” A landmark study in Nature Neuroscience, published a few days after Whelan’s letter, found that the commercially obtained COVID-19 spike protein (S1) injected into mice readily crossed the blood-brain barrier, was found in all 11 brain regions examined and entered the parenchymal brain space (the functional tissue in the brain). The researchers acknowledged that such widespread entry into the brain could explain the diverse neurological effects of S1 such as encephalitis, respiratory difficulties and anosmia (the loss of smell). The injected spike protein was also found in the lung, spleen, kidney and liver of the mice. A second study published in December, 2020, in Neurobiology of Disease reported that the SARS-CoV-2 spike proteins showed a direct negative impact on endothelial cells and provide “plausible explanations” for the neurological consequences observed in patients with COVID-19. The researchers demonstrated that the angiotensin-converting enzyme 2 (ACE2), a known binding target for the SARS-CoV-2 spike protein, is “ubiquitously expressed throughout various vessel calibers in the frontal cortex.” In another investigation, researchers studying brain tissues from 13 fatal COVID-19 cases found pseudovirions (spike, envelope and membrane proteins without viral RNA) present in the endothelia of microvessels of all 13 brains. They concluded that ACE2+ endothelial damage is a central part of SARS-CoV-2 pathology and may be induced by the spike protein alone. Injection of the full-length S1 spike subunit in the tail vein of mice, as part of the same study, led to neurologic signs (increased thirst, stressed behavior). An observed complication of SARS-CoV-2 infection in children is similar to the atypical Kawasaki disease shock syndrome characterized by multisystemic hyperinflammation, edema and vasculitis (MIS-C) that Whelan treats. Research has found SARS-CoV-2 spike protein alone to be a potent inductor of endothelial dysfunction, suggesting that “manifestations of COVID-19 shock syndrome in children can be at least partially attributed to its action.” Let’s now circle back to the concerns voiced by Whelan in his letter to the FDA:
“I am concerned about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein have the potential to cause microvascular injury to the brain, heart, liver and kidneys in a way that does not currently appear to be assessed in safety trials of these potential drugs.”

Whelan was referring to the fact that mRNA vaccines work by incorporating the genetic blueprint for the key spike protein on the virus surface into a formula that — when injected into humans — instructs our own cells to make the spike protein. In theory, the body then will make antibodies against the spike protein to protect against SARS-CoV-2 infection. The problem with this scenario, as we saw above, is that the spike protein alone — which the mRNA vaccines instruct the body to make — has been implicated as a key cause of injury and death in COVID-19 infections. Based on the research conducted to date, it is very likely that some recipients of the spike protein mRNA vaccines will experience the same symptoms and injuries associated with the virus. Again according to Whelan, “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidney … were not assessed in the safety trials.” Whelan also stated in his letter that “particular caution will be required with regard to the potential widespread vaccination of children before there are any real data on the safety or effectiveness of these vaccines…” Sadly highlighting Whelan’s concerns, a 17-year-old was recently hospitalized in the ICU in Israel complaining of severe pains in his chest a few days after receiving the second dose of the coronavirus vaccine. Since the widespread introduction of these vaccines on Dec. 14, 2020, Children’s Health Defense has been following the reports filed with the Vaccine Adverse Event Reporting System (VAERS), the media and emails from individuals and family members who have experienced adverse vaccine reactions. As of Jan. 29, 11,249 adverse events had been reported to OpenVAERS related to the two mRNA COVID-19 vaccines. The reports included 501 deaths, 1066 hospitalizations, 2443 urgent care visits, 1447 office visits and 147 cases of anaphylaxis. What is concerning is that these reports are just the tip of the iceberg. A 2010 Harvard-executed study commissioned by the Department of Health and Human Services (HHS) revealed that reported vaccine injuries to VAERS represent an estimated 1% of actual injuries. Even vaccine manufacturers have calculated at least a “ fifty-fold underreporting of adverse events.” On Dec. 18, 2020, Robert F. Kennedy, Jr., Children’s Health Defense chairman and chief legal counsel, wrote to Dr. David Kessler, then-co-chair of Biden transition’s coronavirus task force and now the chief scientific officer of President Biden’s COVID-19 response, requesting that Kessler consider the long-overdue need for a comprehensive, high-integrity system to monitor adverse outcomes following vaccination. This request has urgent significance in light of the FDA’s decision to authorize emergency use of the two mRNA vaccines following abbreviated pre-approval clinical trials. Since COVID-19 vaccine companies are immune from liability for injuries caused by their products, our public health regulators have an amplified responsibility to monitor adverse events. To date, we have not received a response from Kessler. Children’s Health Defense shares the same concerns as Whelan and numerous other clinicians and scientists who have spoken out about lack of adequate safety and efficacy testing prior to widespread distribution of the vaccines, especially in children. Ignoring these valid and scientifically supported warnings may result in hundreds of millions of people suffering potentially deadly injuries or permanent damage following vaccination. It will also further erode the dwindling confidence that our country has in our federal regulatory agencies to protect the health of all Americans.



36-Year-Old Doctor Dies After Second Dose of COVID Vaccine
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... d-vaccine/
Category: healthNews
Published: February 12, 2021

Description: News reports attributed Dr. Barton Williams’ death to multisystem inflammatory syndrome (MIS-A) caused by asymptomatic COVID, though he never tested positive for the virus.

doctor-dies-Covid-vaccine.jpg

The Centers for Disease Control and Prevention (CDC) is investigating the death of a 36-year-old doctor in Tennessee who died Feb. 8, about a month after receiving the second dose of a COVID vaccination. According to news reports, Dr. Barton Williams died from the adult form of multisystem inflammatory syndrome (MIS-A), a condition caused when the immune system attacks the body resulting in multi-system organ failure. MIS-A is considered extremely rare. The Daily Memphian and other news sources reported that those involved in the investigation believe Williams developed MIS-A in response to an asymptomatic case of COVID-19, not the vaccine. Dr. Stephen Threlkeld, an infectious disease specialist who treated Williams and is working with the CDC to investigate the death, told a Memphis ABC News affiliate that Williams tested negative for COVID while in the hospital and that Williams had told him that to his knowledge, he had not the virus. However, Threlkeld said testing revealed “two types of antibodies in [Williams’] system — one type of antibody that results from a natural COVID infection, and a second type of antibody from the vaccine.” Asked whether the vaccine, rather than an asymptomatic case of COVID, could have caused Williams to develop MIS-A, Threlkeld said: “Everyone who has had [MIS-A], has had the infection. There has been no case published yet of someone who has been documented to have this problem, who has been vaccinated in the past.” Threlkeld also said: “This is not a reason, not to get the vaccine. It’s a reason to get the vaccine, because only people who have had the infection have had this occur.”



But Lyn Redwood, RN, MSN, president emerita of Children’s Health Defense questioned the preliminary findings that ruled out the vaccine in favor of a rare reaction to an asymptomatic case of COVID. Redwood pointed to research that described temporal associations between Kawasaki disease (KD), a disease that exhibits symptoms similar to MIS-C such as high fevers, rash and blood vessel inflammation, and a wide variety of vaccines, including hepatitis A and B, rotavirus, influenza, DPT or DTaP, pneumococcal vaccines and yellow fever. “Scientists who have studied the “distinctive immune system characteristics” of children with Kawasaki disease, a disease which is very similar to MIS-C, acknowledge that the ‘antigenic stimulation’ set in motion by vaccines and other biologics has the capacity to create “immunologic interference,” Redwood said. “Is it possible that the MIS-C and MIS-A are the result of ‘pathogen priming,’ a mechanism that other researchers euphemistically describe as ‘immune enhancement’?” “Pathogen priming can arise when the proteins in viral vaccines are so similar (‘homologous’) to proteins in humans that they subsequently trigger out-of-control autoimmunity or hypersensitivity reactions such as shock syndrome and delayed anaphylaxis,” Redwood said. As Redwood reported earlier this week, research has found the SARS-CoV-2 spike protein alone — without the virus — to be a potent inductor of endothelial dysfunction, suggesting that “manifestations of COVID-19 shock syndrome in children can be at least partially attributed to its action.” MIS-C, the childhood version of multisystem inflammatory syndrome, is also rare, but more common in children than adults. Children with MIS-C often exhibit symptoms similar to Kawasaki disease. In her Feb. 10 article, Redwood referred to a public comment submitted in December to the U.S. Food and Drug Administration from Dr. J. Patrick Whelan, a pediatric rheumatologist, warning about the potential for mRNA vaccines designed to create immunity to the SARS-CoV-2 spike protein to instead cause injuries. Both the Pfizer and Moderna vaccines, the only two so far approved for emergency use in the U.S., use mRNA technology. Whelan’s training (at Harvard, Texas Children’s Hospital and Baylor College of Medicine) includes degrees in biochemistry, medicine and rheumatology. For 20 years, he worked as a pediatric rheumatologist. He currently specializes in treating children with multisystem inflammatory syndrome (MIS-C), which has been associated with coronavirus infections. In his comments to the FDA, Whelan wrote:
“I am concerned about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein have the potential to cause microvascular injury to the brain, heart, liver and kidneys in a way that does not currently appear to be assessed in safety trials of these potential drugs.”

Whelan was referring to the fact that mRNA vaccines work by incorporating the genetic blueprint for the key spike protein on the virus surface into a formula that — when injected into humans — instructs our own cells to make the spike protein. In theory, the body then will make antibodies against the spike protein to protect against SARS-CoV-2 infection. “The problem with this scenario,” said Redwood, “is that the spike protein alone — which the mRNA vaccines instruct the body to make — has been implicated as a key cause of injury and death in COVID-19 infections.” Based on the research conducted to date, Redwood said, it is very likely that some recipients of the spike protein mRNA vaccines will experience the same symptoms and injuries associated with the virus. Again according to Whelan, “the potential to cause microvascular injury (inflammation and small blood clots called microthrombi) to the brain, heart, liver and kidney … were not assessed in the safety trials.” Last year, Canadian researchers identified Kawasaki disease as a “condition of interest” for pediatric vaccine safety surveillance, citing ongoing reports of KD to passive systems monitoring adverse events following immunization (AEFI). Two studies — one conducted in Singapore and one in the U.S. — have highlighted an association between the 13-valent pneumococcal conjugate vaccine (PCV13) and Kawasaki disease:
* The Singapore researchers looked at all young children (under age two) hospitalized for KD in their hospital from 2010 to 2014, considering children in whom KD onset took place within one month of PCV13 vaccination. Writing in Nature in 2019, the authors denied any overall increased risk but reported “an approximate two fold increased risk of Complete KD within the 28 day risk interval following receipt of the first dose of PCV13.” The researchers closed with an “urgent” plea to confirm their findings.
* The U.S. study, a 2013 Vaccine Safety Datalink analysis by Kaiser Permanente researchers at eight managed care organizations, also looked at children two years and under, comparing those who received PCV13 from 2010-2012 to same-age children who received the Prevnar-7 vaccine (PCV7) in the mid-2000s. For the PCV13-vaccinated infants and toddlers, the likelihood of developing KD was 1.94 times higher than for those who received PCV7 — again representing a finding deserving of “further investigation.”



New Analysis: Pfizer Vaccine Killed ‘About 40 Times More Elderly Than the Disease Itself Would Have Killed’
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... han-covid/
Category: healthNews
Published: March 2, 2021

Description: A re-analysis of data from the Israeli Health Ministry concluded Pfizer’s COVID vaccine killed “about 40 times more (elderly) people than the disease itself would have killed” during a recent five-week vaccination period, and 260 times more younger people than would have died from the virus.



While in January a group of independent doctors concluded that experimental COVID-19 vaccines are “not safer” than the virus itself, a new analysis of vaccine-related death rates in Israel demonstrates that this may indeed be the case to dramatic levels. A re-analysis of published data from the Israeli Health Ministry by Dr. Hervé Seligmann, a member of the faculty of Medicine Emerging Infectious and Tropical Diseases at Aix-Marseille University, and engineer Haim Yativ reveal, in short, that the mRNA experimental vaccine from Pfizer killed “about 40 times more (elderly) people than the disease itself would have killed” during a recent five-week vaccination period. Among the younger class, these numbers are compounded to death rates at 260 times what the COVID-19 virus would have claimed in the given time frame. While the full mathematical analysis may be found in the article itself, the authors demonstrate how among “those vaccinated and above 65, 0.2% … died during the three-week period between doses, hence about 200 among 100,000 vaccinated. This is to be compared to the 4.91 dead among 100,000 dying from COVID-19 without vaccination.” “This scary picture also extends to those below 65,” the researchers continued. During the five-week vaccination process “0.05%, meaning 50 among 100,000, died. This is to be compared to the 0.19 per 100,000 dying from COVID-19 (who) are not vaccinated … Hence the death rate of this age group increased by 260 (times) during this five-week period of the vaccination process, as compared to their natural COVID-19 death rate.” As reported by IsraelNationalNews (INN), Seligmann is of Israeli-Luxembourg nationality, has a biology degree from Hebrew University of Jerusalem, and has written more than 100 scientific publications. INN reports the researchers “have no conflicts or interests other than having children in Israel.” Yativ and Seligmann stipulate that even these “estimated numbers of deaths from the vaccine are probably much lower than actual numbers as it accounts only for those defined as COVID-19 deaths for that short time period and does not include AVC and cardiac (and other) events resulting from the inflammatory reactions.” Nor do these numbers “account for long-term complications,” they write. In addition, within several months they expect “mid- and long-term adverse effects of the vaccination as ADE (Antibody-dependent Enhancement)” begins to become manifest in those who have received the experimental Pfizer vaccine. As explained by America’s Frontline Doctors (AFLDS), ADE “is when anti-COVID antibodies, created by a vaccine, instead of protecting the person, cause a more severe or lethal disease when the person is later exposed to SARS-CoV-2 in the wild. The vaccine amplifies the infection rather than preventing damage.” AFLDS provides an example of a vaccine produced to fight the Dengue fever, which resulted in deaths of 600 children in the Philippines due to ADE, and the filing of criminal charges against the decision-makers in 2019. For these reasons and more, AFLDS and many other doctors strongly discourage the use of these experimental vaccines for most people while only acknowledging that it may be plausible for those over 70 years of age, yet acknowledging that such injections are “a higher risk than early or prophylactic treatment with established medications” (sources here, here, here, and here). Given these death rates, Yativ and Seligmann also have harsh criticism for the severe pressure being imposed upon the population by Israeli authorities to receive these shots. According to INN, the researchers call these draconian efforts “a new Holocaust.” In the past weeks, Israel’s government made headlines when they adopted a “green pass” system, allowing people who have been injected to receive a green code, which then grants them entry into places such as entertainment and leisure facilities. As the country reopens after a two-month lockdown, the green pass would be given only to those who had been injected, not to people who tested negative for the virus. The proposed benefits include access to “non-essential” businesses as well as not being required to self-isolate if identified as a close contact of a confirmed case of COVID-19, and not having to self-isolate after a return from what the government calls a “red location.” Despite there being no proof that these experimental vaccines actually prevent transmission of the virus, Israel’s minister for health, Yuli Edelstein, said upon the release of the vaccine “passport” that “(g)etting vaccinated is a moral duty. It is part of our mutual responsibility.” He went further, declaring, “Whoever does not get vaccinated will be left behind.” The green pass needs renewing every six months, and despite holding one, an individual must still abide by masking and physical distancing rules. The Jerusalem Post also reported that legislation is being considered to grant employers the right to refuse unvaccinated people entry into the workplace. Such measures prompted Business Insider to describe the country as “waging a war on the unvaccinated.” Meanwhile, Dr. Anthony Fauci, chief medical adviser to President Joe Biden, has styled Israel’s vaccination response as “extraordinarily good.”



CDC Ignores Inquiry Into Increasing Number of Deaths, Injuries Reported After COVID Vaccines
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... d-vaccine/
Category: healthNews
Published: March 19, 2021

Description: VAERS data released today showed 38,444 reports of adverse events following COVID vaccines, including 1,739 deaths and 6,286 serious injuries since Dec. 14, 2020.
Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines showed 38,444 reports of adverse events since Dec. 14, 2020. On March 8, The Defender contacted the CDC with questions about how the agency is investigating reports of deaths and injuries after COVID vaccines. We provided a written list of questions asking the status of investigations on deaths reported in the media, if autopsies are being done, the standard for determining whether an injury is causally connected to a vaccine and the known issues with VAERS — namely whether healthcare providers are reporting all injuries and deaths that might be connected to the COVID vaccine, and what education initiatives are in place to encourage and facilitate proper and accurate reporting. We asked for a reply within two days. As of today, 11 days later, the CDC has not answered our questions. Instead, when we call them, they respond saying, “they have received our email, they will escalate it and it is in the system.” When we asked if we could speak with the person reviewing the email, we were told that information could not be provided. When we emailed them to follow up, we received no response. Every Friday, VAERS makes public all vaccine injury reports received by the system as of Friday of the previous week. The 38,444 adverse events reported between Dec. 14, 2020, and March 11 include 1,739 deaths and 6,286 serious injuries. This week’s data included reports of 478 cases of Bell’s Palsy. Of those, 66% of cases were reported after Pfizer-BioNTech vaccinations — almost twice as many as reported (36%) following vaccination with the Moderna vaccine. The first Johnson & Johnson (J&J) COVID vaccine was administered in the U.S. on March 2. As of March 11, nine anaphylactic reactions associated with J&J’s vaccine had been reported to VAERS. As The Defender reported earlier this month, the J&J vaccine contains polysorbate 80, known to trigger allergic reactions, The Moderna and Pfizer vaccines contain polyethylene glycol (PEG), also known to trigger anaphylactic reactions. In the U.S., 98.2 million COVID vaccine doses had been administered as of March 11.

vaers_cdc_vaccine_injury_report.png

VAERS is the primary mechanism for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. For the most part, today’s data reflect trends that have emerged since The Defender first began tracking VAERS reports related to COVID vaccines. This week’s VAERS data show:
* Of the 1,739 deaths reported as of March 11, 30% occurred within 48 hours of vaccination, 21% occurred within 24 hours, and 46% occurred in people who became ill within 48 hours of being vaccinated. By comparison, during the same period, there were only 85 deaths reported following flu vaccines.
* Nineteen percent of deaths were related to cardiac disorders.
* Fifty-three percent of those who died were male, 44% were female and the remaining death reports did not include gender of the deceased.
* The average age of those who died was 77.9 and the youngest death was an 18-year-old.
* As of March 11, 289 pregnant women had reported adverse events related to COVID vaccines, including 90 reports of miscarriage or premature birth. None of the COVID vaccines approved for Emergency Use Authorization has been confirmed safe or effective for pregnant women, although J&J said earlier this month it would begin testing on pregnant women, infants and the immunocompromised.
* There were 1,689 reports of anaphylaxis, with 59% of cases attributed to the Pfizer-BioNTech vaccine and 41% to Moderna.
The average age of death reported remains 77.9, however the youngest reported death this week dropped from 23 to 18. According to VAERS, the teenager developed fatigue, body aches and a headache one day after receiving the Moderna vaccine on March 3. On March 5 he complained of chest pain, and died in his sleep later that day. The latest data also includes the report of a 22-year-old woman with a “significant, lifelong underlying medical condition” who died 24 days after the vaccine. According to the CDC’s website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.” To date, the only information the CDC has published related to the investigation of COVID vaccine-related deaths and how those investigations were conducted is a COVID-19 Vaccine Safety Update via the Advisory Committee on Immunization Practices (ACIP) published on Jan. 27. The safety update analyzed only the 198 reported deaths that occurred within the first month after the first COVID vaccine was administered in the U.S. It is unknown whether the CDC has investigated any of the 1,541 reported deaths since or, if investigations were conducted, what the results showed. On March 16, The Defender reported that more than 20 countries suspended use of AstraZeneca’s COVID vaccine after reports of blood clots, some resulting in death, in healthy people who received the vaccine. The World Health Organization (WHO) said an ongoing analysis by its vaccines advisory committee had not established a causal link between the vaccine and blood clots and that countries should keep using it. On March 18, the European Medicine Agency (EMA) released the results of its investigation into the AstraZeneca vaccine. The EMA said Thursday the vaccine “may be associated with very rare cases of blood clots,” but the agency still considers it to be “safe and effective” and countries should continue to use it. The EMA determined AstraZeneca’s vaccine was not associated with an “overall risk” of blood clots in those vaccinated and there was no evidence of a problem related to specific batches of the vaccine or manufacturing sites, The Defender reported. According to Reuters, about a dozen countries resumed use of AstraZeneca’s COVID vaccine today, including Germany, Indonesia and France as EU and British regulators said the benefits outweighed any risks of potential blood clots. AstraZeneca’s vaccine is not yet approved for emergency use in the U.S. On March 18, The Defender reported Pfizer’s chief financial officer told analysts and investors during a recent earnings call that the company plans to turn its COVID vaccine with German company BioNTech into an even bigger cash cow once the pandemic ends. Pfizer’s vaccine is already the second-highest revenue-generating drug in the world. The vaccine maker expects revenues of $15 billion in 2021 based on current contracts for its COVID vaccine, but that number could double as Pfizer says it can potentially deliver 2 billion doses this year. Leaked documents obtained as a result of a cyberattack on the EMA and reviewed by The BMJ revealed regulators had major concerns over unexpectedly low quantities of intact mRNA in batches of the Pfizer’s COVID vaccine developed for commercial production, as reported this week by The Defender. A leaked email identified “a significant difference in % RNA integrity/truncated species” between the clinical batches and proposed commercial batches — from around 78% to 55%. Pfizer was not manufacturing vaccines to the specifications expected, and the impact of this loss of RNA integrity on safety and efficacy of the vaccine was not identified, according to the email. The EMA responded by filing two “major objections” with Pfizer, along with a host of other questions it wanted addressed. It’s unclear if the agency’s concerns were satisfied.



‘Breaking Through’ — States Report Growing Number of COVID Cases Among Fully Vaccinated
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... accinated/
Category: healthNews
Published: March 31, 2021

Description: Washington, Florida, South Carolina, Texas, New York, California and Minnesota have all reported breakthrough cases of COVID.
The Washington State Department of Health (DOH) announced Tuesday it is investigating reports of people who tested positive for COVID more than two weeks after being fully vaccinated against the disease. According to Kiro 7 News, a CBS affiliate in Washington, the DOH is investigating reports of the so-called “breakthrough cases,” which it said are expected with any vaccine. Each case was confirmed with a polymerase chain reaction (PCR) test or a positive antigen test more than two weeks after the person had been fully vaccinated. A majority of people with confirmed vaccine breakthrough experienced mild symptoms, if any. However, since Feb. 1, eight people with vaccine breakthrough cases were hospitalized and the DOH “is investigating two potential vaccine breakthrough cases where the patients died. Both patients were more than 80 years old and suffered underlying health issues,” officials said in a press release. Washington isn’t the only state reporting breakthrough cases. Florida, South Carolina, Texas, New York, California and Minnesota have also reported cases of fully vaccinated people testing positive and becoming ill with COVID. The Florida Department of Health in Volusia County had six documented breakthrough cases, Sumter County had six and Lake County had 26 cases, according to emails from each county spokespersons. Dr. Sunil Joshi, president of the Duval County Medical Foundation, compared the COVID vaccine to the flu vaccine. “It’s like the flu shot, for instance, right. We know, we encourage people to get the flu vaccine. That doesn’t mean that you’re not going to get the flu. But the disease is significantly lessened,” Joshi said. “So remember, the whole goal for this, from the very beginning, has been to keep people out of the hospital. And so anything positive after the vaccine is not unusual, it can happen.” In Charleston, South Carolina, the Department of Health and Environmental Control (DHEC) identified 134 breakthrough cases in those fully vaccinated across the state. In the past month alone, Roper St. Francis Healthcare treated four patients in the hospital and were aware of 10 other “breakthrough” cases that did not need hospitalization. The Medical University of South Carolina reported seven COVID cases in fully vaccinated people. Roper Hospital is working with DHEC to analyze positive test results to see if variants may play a role. “All of these individuals we identify who get infected or even hospitalized despite receiving two doses, that virus will be sent on to DHEC for further analysis,” infectious disease physician Dr. Kent Stock said. “The question is, is that phenomenon influencing these numbers?” In Wichita Falls, Texas, seven vaccine breakthrough cases were reported Monday in those fully vaccinated against COVID. Of the seven cases, six had the Pfizer vaccine and one had Moderna. “We’ve been watching that since the very beginning, since vaccinations started and so we started noticing it was just maybe one per week, two per week, now we are currently at seven,” Amy Fagan, assistant health director of the Wichita Falls Wichita County Public Health District, said. As of March 24, Minnesota had identified 89 “breakthrough” COVID infections with a small number resulting in hospitalization, according to Star Tribune. Out of caution, the state is reviewing the cases to see if they have anything in common, state infectious disease director Kris Ehresmann said. “A cluster of cases vaccinated at the same site could suggest a handling problem with the vaccine, or that a lot was tainted,” she said. When asked about Minnesota’s vaccine breakthrough cases during a White House press briefing on March 26, Dr. Anthony Fauci, President Biden’s chief medical advisor, said: “This is something we take seriously and follow closely. You will see breakthrough infections in any vaccination when you’re vaccinating literally tens and tens and tens of millions of people. So in some respects, that’s not surprising.” According to Fox News, a Long Island, New York woman tested positive for COVID Tuesday — more than a month after receiving her second dose of the Moderna vaccine meant to protect against the virus. “I was shocked,” Rosen said. “I’m the 4.9% that got Moderna and actually got COVID.” In a March 23 letter to the editor of the New England Journal of Medicine, eight physicians reported on a study they conducted on breakthrough cases at the University of California, San Diego and University of California, Los Angeles (UCLA) health systems. According to the letter, UCLA instituted an optional testing program on Dec. 26, 2020, for asymptomatic healthcare workers using PCR nasal testing in an effort to detect asymptomatic SARS-CoV-2 infections after vaccination. From Dec. 16, 2020, through Feb.9, 2021, a total of 36,659 healthcare workers received the first dose of a COVID vaccine, and 28,184 of these persons (77%) received the second dose. Among those vaccinated, 379 people tested positive for COVID at least one day after vaccination, and the majority (71%) tested positive within the first two weeks after the first dose. After receiving both vaccinations, 37 healthcare workers tested positive. According to the study, the risk of testing positive for COVID after vaccination was between 0.97% and 1.19% –– rates higher than the risks reported in the Moderna and Pfizer vaccine trials. As The Defender reported in December 2020, one explanation for “breakthrough cases” in the fully vaccinated may be the use of polyethylene glycol (PEG) in mRNA COVID vaccines like Moderna and Pfizer. Studies have found approximately 72% of people may have PEG antibodies. In those people, the antibodies may cause an anaphylactic reaction to the vaccine. Or, the antibodies may break down and degrade the PEG-coated mRNA in the vaccine before it gets a chance to get into the cell and start programming the production of spike proteins, resulting in the vaccine being less effective.



Number of COVID Vaccine Injuries Reported to VAERS Surpasses 50,000, CDC Data Show
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... vaers-cdc/
Category: healthNews
Published: April 2, 2021

Description: VAERS data released today showed 50,861 reports of adverse events following COVID vaccines, including 2,249 deaths and 7,726 serious injuries between Dec. 14, 2020 and March 26, 2021.
Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines revealed steadily rising numbers, but no new trends. VAERS is the primary mechanism for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Every Friday, VAERS makes public all vaccine injury reports received to the system as of Friday of the previous week. Today’s data show that between Dec. 14, 2020, and March 26, a total of 50,861 total adverse events were reported to VAERS, including 2,249 deaths — an increase of 199 over the previous seven days — and 7,726 serious injuries, up 631 over the same time period. Of the 2,249 deaths reported as of March 26, 28% occurred within 48 hours of vaccination, 19% occurred within 24 hours and 43% occurred in people who became ill within 48 hours of being vaccinated. In the U.S., 136.7 million COVID vaccine doses had been administered as of March 26.

vaers-vaccine-injuries-reported-cdc-march-26.png

This week’s VAERS data show:
* 19% of deaths were related to cardiac disorders.
* 45% of those who died were male, 43% were female and the remaining death reports did not include gender of the deceased.
* The average age of those who died was 77.7 and the youngest death was an 18-year-old.
* As of March 26, 341 pregnant women had reported adverse events related to COVID vaccines, including 104 reports of miscarriage or premature birth.
* Of the 578 cases of Bell’s Palsy reported, 63% of cases were reported after Pfizer-BioNTech vaccinations — almost twice as many as reported (36%) following vaccination with the Moderna vaccine. Seven cases of Bell’s Palsy were reported with Johnson & Johnson (J&J) vaccine (1%).
* There were 2,578 reports of anaphylaxis, with 53% of cases attributed to the Pfizer-BioNTech vaccine, 44% to Moderna and 3% to J&J vaccine, which was rolled out in the U.S. on March 2.
* Using a broadened search for any reference to anaphylaxis in chart notes resulted in 15,193 reports, with 52% of cases attributed to Pfizer’s COVID vaccine, 45% to Moderna and 3% to J&J. With each vaccine, nearly 42% of anaphylactic reports occurred in people aged 17-44.
According to the CDC’s website, “the CDC follows up on any report of death to request additional information and learn more about what occurred and to determine whether the death was a result of the vaccine or unrelated.” To date, the only information the CDC has published related to the investigation of COVID vaccine-related deaths and how those investigations were conducted is a COVID-19 Vaccine Safety Update via the Advisory Committee on Immunization Practices, published Jan. 27. An interview in MedPage Today highlighted the shortfalls of the post-marketing surveillance of the COVID vaccine. Aaron Kesselheim, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital in Boston, said we are seeing a lot of spontaneous reporting, a lack of formal post-approval studies because vaccines have only received Emergency Use Authorization and vaccines being given outside the healthcare systems — interfering with the ability to rigorously collect observational data. Although the CDC and U.S. Food and Drug Administration (FDA) have various systems in place to monitor the safety of vaccines, they are not “up and running” and do not have adequate resources behind them, Kesselheim said. According to Kesselheim, there’s essentially nobody keeping track of COVID adverse reactions in the U.S. and no long-term safety data, but emphasized that this new mRNA technology is “extremely effective and extremely safe.” On March 8, The Defender contacted the CDC with questions about reported deaths and injuries related to COVID vaccines. We provided a written list of questions about how the CDC conducts investigations into reported deaths, the status of investigations on deaths reported in the media, if autopsies are being done and the standard for determining whether an injury is causally connected to a vaccine. We also inquired about whether healthcare providers are reporting all injuries and deaths that might be connected to the COVID vaccine, and what education initiatives are in place to encourage and facilitate proper and accurate reporting. It took the CDC 22 days to respond to our repeated inquiries. When someone did, the person told us the agency had never received the questions — even though the employees we talked to several times said their press officers were working through the list of questions and were reviewing the email we sent. We provided the questions again yesterday, and requested a response by April 7.
Breakthrough cases
On March 31, The Defender reported on the increasing number of “breakthrough cases” of COVID in fully vaccinated people. Washington, Florida, South Carolina, Texas, New York, California and Minnesota have all reported breakthrough cases of COVID, some of which have resulted in hospitalization and death. Investigations are underway to determine if there were problems with the vaccines or if people had been infected with a variant. When asked about the increasing number of breakthrough cases during a White House press conference, Dr. Anthony Fauci, President Biden’s chief medical advisor, said it is something they will take seriously and follow closely, but breakthrough infections happen with any vaccination. CDC issues new travel guidance, vaccine passports stir controversyThe CDC today issued new travel guidance stating that fully vaccinated Americans traveling within the U.S. do not have to get tested for COVID before or after their trip, and do not need to self-quarantine when they return home. On March 29, The Defender reported that the Biden administration and private companies are working to develop vaccine passports that would require Americans to prove they’ve been vaccinated against COVID as the country opens. Dr. Naomi Wolf, founder and CEO of Daily Clout, said the passport system really isn’t about the vaccine. It’s about your data, and “once this rolls out you don’t have a choice about being part of the system.” Rep. Pete Sessions (R-Texas) said that vaccine credentials are a complete government overstep that will undermine public trust and substantially limit normal day-to-day essential activities. Rep. Lauren Boebert (R-Colo.) said “vaccine passports are unconstitutional. Period.” On March 26, New York launched a digital vaccine passport system known as Excelsior Pass that residents can use to prove they’ve been vaccinated or recently tested negative for infection. The New York system, built on IBM’s digital health pass platform, will be used at dozens of events, including arts and entertainment venues.
J&J makes headlines with manufacturing mix-up, report of severe allergic reaction
As The Defender reported April 1, 15 million doses of J&J’s vaccine failed quality control after workers at a Baltimore manufacturing plant negligently put an AstraZeneca ingredient in J&J’s COVID vaccine. The mix-up forced regulators to delay authorization of the plant’s production lines and prompted an investigation by the FDA. On March 31, Business Insider reported that a 74-year-old Virginia man suffered a rare reaction to J&J’s vaccine that caused a painful rash to spread across his entire body and skin to peel off. Richard Terrell told local news station WRIC he began suffering strange symptoms four days after receiving the vaccine. “I began to feel a little discomfort in my armpit and then a few days later I began to get an itchy rash, and then after that I began to swell and my skin turned red,” Terrell said. The rash spread to his entire body and his skin peeled off. He went to the emergency room, where doctors determined that he had experienced an adverse reaction to the COVID vaccine.
AstraZeneca suspended in Germany and Canada
On March 31, The Defender reported that Germany indefinitely suspended use of the Oxford-AstraZeneca COVID vaccine for anyone under 60 following advice from STIKO, the country’s independent vaccine committee and external experts. The committee investigated reports of blood clots, some fatal, in people who received the vaccine and decided to give the vaccine only to people 60 or older unless they belong to a high-risk category where the benefits outweigh the risk of a serious side-effect. As The Defender reported on March 30, several regions of Germany, including Berlin and Munich, had temporarily paused the vaccine for people under 60 after Germany’s vaccine regulator disclosed 31 cases of a rare brain blood clot, nine of which resulted in deaths. The decision was made as a precaution ahead of a meeting with national medical regulators scheduled for later in the day where it was decided to indefinitely suspend the vaccine. On March 30, Canada announced it was suspending AstraZeneca’s vaccine for people under age 55 following concerns it might be linked to rare blood clots, The Defender reported. Health Canada demanded AstraZeneca conduct a detailed study on the risks and benefits of its COVID vaccine across multiple age groups, and suspended the vaccine for younger groups pending the outcome of that review. On March 24, Health Canada updated the product information for AstraZeneca’s COVID vaccines to warn of the risk of rare blood clots associated with low levels of blood platelets following vaccinations — a stark reversal from Canada’s former position.



Scientists Challenge Health Officials on Vaccinating People Who Already Had COVID
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... ing-covid/
Category: healthNews
Published: April 5, 2021

Description: Scientists warn vaccinating people who already COVID could potentially cause harm, or even death.
Since the first COVID-19 vaccine received Emergency Use Authorization in the U.S., some physicians and scientists have challenged the recommendation by U.S. health agencies that people who have already had COVID and as a result acquired natural immunity still get the vaccine. Some experts say the science to support vaccinating those primed with COVID doesn’t exist and there’s a potential risk of harm, including death, in vaccinating those who’ve already had the disease or were recently infected. In December 2020, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices issued a report authored by 15 scientists that falsely claimed a Pfizer study proved the vaccine was highly effective or showed “Consistent high efficacy” for people who’d already had coronavirus — “SARS-CoV 2.” Award-winning scientist and Congressman Thomas Massie (R-Ky.) called out the CDC when he found that vaccine studies showed no benefit to people who had coronavirus and that getting vaccinated didn’t change their odds of getting reinfected. The CDC claimed “the COVID vaccine would save your life or save you from suffering, even if you’ve already had the virus and recovered, which has not been demonstrated in either the Pfizer or Moderna trials,” Massie said in an interview with Full Measure. Massie contacted officials at the CDC about the misinformation. They acknowledged it was false, but instead of correcting it, tried to rephrase their mistake. Massie and other scientists said the new wording still wrongly implies vaccines work in people who previously had COVID. “And instead of fixing it, they proposed repeating it and just phrasing their mistake differently. So, at that point, right now I consider it a lie. I think the CDC is lying about the efficacy of the vaccine based on the Pfizer trials, for those who have already had the coronavirus,” Massie said. The CDC recommends people get vaccinated even if they’ve already had COVID, as experts do not know how long “you are protected from getting sick again after recovering from COVID, and it is possible — although rare — that you could be infected with the virus that causes COVID again.” On Feb. 23, Francis Collins, director of the National Institutes of Health (NIH), published a blog post stating that people who’ve had COVID still needed the vaccine, while referencing a study that suggested they didn’t. Citing a pre-print published on medRxiv, Collins wrote that the immune response to the first vaccine dose in a person who’s already had COVID is equal to, or in some cases better, than the response to the second dose in a person who hasn’t had COVID. He said the “results raise the possibility that one dose might be enough for someone who’s been infected with SARS-CoV-2 and already generated antibodies against the virus.” Yet, Collins made the case that people who have already had COVID would have a robust antibody response when later exposed to the virus — whether that’s through natural exposure or via the spike protein from a COVID vaccine. To better understand immune memory of SARS-CoV-2, researchers led by Drs. Daniela Weiskopf, Alessandro Sette and Shane Crotty from the La Jolla Institute for Immunology analyzed immune cells and antibodies from nearly 200 people who had been exposed to COVID and recovered. The results, published in Science, showed the immune systems of more than 95% of people who recovered from COVID had durable memories of the virus up to eight months after infection. Previous studies showed that natural infection induced a strong response, but this study showed that response lasted, Weiskoph said. Another study in Nature assessed the lasting immunogenic effect of T-cell reactivity to SARS and SARS-2. Data showed that natural immunity was very robust — and likely more robust than any immunity derived from a vaccine.
Increased risk of vaccine injury in those with previous infection
On March 19, the U.S. Food and Drug Administration (FDA) issued an emergency authorization for a new test to detect COVID infections — one that stands apart from the hundreds already authorized, reported STAT. Developed by Seattle-based Adaptive Biotechnologies in partnership with Microsoft, the new test, called T-Detect COVID, looks for signals of past infections in the body’s adaptive immune system — specifically, the T cells that help the body remember what its viral enemies look like. Adaptive’s approach involves mapping antigens to their matching receptors on the surface of T cells, which would help scientists unlock information to help diagnose past COVID infections. Dr. Dara Udo, urgent and immediate care physician at Westchester Medical Group, received the COVID vaccine a year after having the disease and had a very strong immune response very similar to what she experienced while having COVID. In an opinion piece published by The Hill, Udo explained that infection from any organism, including COVID, activates several different arms of the immune system, some in more robust ways than others and that this underlying activation due to infection or exposure, combined with a vaccination, could lead to overstimulation of the immune response. Udo thought this might explain the symptoms she had, as well as her frontline colleagues who had high rates of COVID antibodies (known as seroprevalence) prior to becoming vaccinated. “For high-risk, vulnerable groups, emerging data suggest that seroprevalence of COVID-19 infection is likely higher than tested and reported. Therefore, a natural question arises of whether there may be a smarter way to administer the vaccines in high seroprevalent groups,” Udo wrote. Udo called for an intentional, well-planned approach to avoid eliciting adverse immune responses in those who had COVID and subsequently get vaccinated. Udo suggested a person already “COVID-primed” may be better off with a one-dose rather than a two-dose vaccine, or that the vaccine administered should be dependent on whether the person already had COVID. For example, someone who is “COVID-naive” might do better with a vaccine like Pfizer or Moderna, while the COVID-primed might need a less robust immune response from the one-dose Johnson & Johnson vaccine. In order to implement this protocol, rigorous, effective and efficient antibody prescreening tools to identify these individuals would be required, Udo said. Dr. Hooman Noorchashm, an accomplished surgeon, patient safety advocate and staunch supporter of the new COVID vaccines, has written several letters to the FDA urging the agency to require pre-screening for SARS-CoV-2 viral proteins in order to reduce COVID vaccine injuries and deaths. According to Noorchasm, it is scientifically established that once a person is naturally infected by a virus, antigens from that virus persist in the body for a long time after viral replication has stopped and clinical signs of infection have resolved. When a vaccine reactivates an immune response in a recently infected person, the tissues harboring the persisting viral antigen are targeted, inflamed and damaged by the immune response. “In the case of SARS-CoV-2, we know that the virus naturally infects the heart, the inner lining of blood vessels, the lungs and the brain,” explained Noorchasm. “So, these are likely to be some of the critical organs that will contain persistent viral antigens in the recently infected — and, following reactivation of the immune system by a vaccine, these tissues can be expected to be targeted and damaged.” Colleen Kelley is an associate professor of infectious diseases at Emory University School of Medicine and principal investigator for Moderna and Novavax phase 3 vaccine clinical trials in Atlanta. In an interview with Huffington Post, Kelley said there have been reported cases in which those who previously had the virus endured harsher side effects after they received their vaccines. “Anecdotally, it does appear that people who may have had COVID-19 before their vaccine do tend to have those longer duration of symptoms,” Kelley added. “But we’re still gathering additional scientific data to really support this.” In a public submission to the FDA, J. Patrick Whelan M.D. Ph.D., expressed similar concern that COVID vaccines aimed at creating immunity against the SARS-CoV-2 spike protein could have the potential to cause microvascular injury to the brain, heart, liver and kidneys in a way that does not currently appear to be assessed in safety trials of these potential drugs. Based on several studies, Whelan said it appeared that the viral spike protein in the SARS-CoV02 vaccines is also one of the key agents causing damage to distant organs that may include the brain, heart, lung and kidney. “Before any of these vaccines are approved for widespread use in humans, it is important to assess in vaccinated subjects the effects of vaccination on the heart,” wrote Whelan. “As important as it is to quickly arrest the spread of the virus by immunizing the population, it would be vastly worse if hundreds of millions of people were to suffer long-lasting or even permanent damage to their brain or heart microvasculature as a result of failing to appreciate in the short-term an unintended effect of full-length spike protein-based vaccines on these other organs.” At the very minimum, Noorchasm said in a letter to FDA officials, “Pfizer and Moderna should “institute clear recommendations to clinicians that they delay immunization in any recently convalescent patients, as well as, any known symptomatic or asymptomatic carriers — and to actively screen as many patients with high cardiovascular risk as is reasonably possible, in order to detect the presence of SARS-CoV-2, prior to vaccinating them.” On March 19, 32-year-old Benjamin Goodman died after receiving Johnson & Johnson’s experimental COVID vaccine. According to a Facebook post by his step-mother, Goodman knew his family’s difficult history with vaccines but got vaccinated at a pop-up vaccine site at a local Walgreen’s because people were pushing the travel pass. Goodman felt ill, experienced a headache, woke up with a fever and chills at 1 a.m., went into cardiac arrest at 4 a.m. and was declared dead two hours later. Like many others, Goodman had not been tested to see if he had previously had COVID or was recently infected. Noorchasm sent a third communication to the FDA warning that deaths like Goodman’s could have been prevented, and that there will be more deaths unless people are screened before being vaccinated. As The Defender reported earlier this month, Noorchashm believes that a #ScreenB4Vaccine campaign could save millions from vaccine injuries. “We are deploying this defensive weapon [the COVID vaccine] wildly indiscriminately in the midst of a pandemic outbreak, while many are ‘the recently infected.’ It is my professional opinion as an immunologist and physician that this indiscriminate vaccination is a clear and present danger to a subset of the already infected,” Noorchasm told The Defender.



Could mRNA Vaccines Permanently Alter DNA? Recent Science Suggests They Might.
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... alter-dna/\
Category: healthNews
Published: April 8, 2021

Description: Research on SARS-CoV-2 RNA by scientists at Harvard and MIT has implications for how mRNA vaccines could permanently alter genomic DNA, according to Doug Corrigan, Ph.D., a biochemist-molecular biologist who says more research is needed.
Over the past year, it would be all but impossible for Americans not to notice the media’s decision to make vaccines the dominant COVID narrative, rushing to do so even before any coronavirus-attributed deaths occurred. The media’s slanted coverage has provided a particularly fruitful public relations boost for messenger RNA (mRNA) vaccines — decades in the making but never approved for human use — helping to usher the experimental technology closer to the regulatory finish line. Under ordinary circumstances, the body makes (“transcribes”) mRNA from the DNA in a cell’s nucleus. The mRNA then travels out of the nucleus into the cytoplasm, where it provides instructions about which proteins to make. By comparison, mRNA vaccines send their chemically synthesized mRNA payload (bundled with spike protein-manufacturing instructions) directly into the cytoplasm. According to the Centers for Disease Control and Prevention (CDC) and most mRNA vaccine scientists, the buck then stops there — mRNA vaccines “do not affect or interact with our DNA in any way,” the CDC says. The CDC asserts first, that the mRNA cannot enter the cell’s nucleus (where DNA resides), and second, that the cell — Mission-Impossible-style — “gets rid of the mRNA soon after it is finished using the instructions.” A December preprint about SARS-CoV-2, by scientists at Harvard and Massachusetts Institute of Technology (MIT), produced findings about wild coronavirus that raise questions about how viral RNA operates. The scientists conducted the analysis because they were “puzzled by the fact that there is a respectable number of people who are testing positive for COVID-19 by PCR long after the infection was gone.” Their key findings were as follows: SARS-CoV-2 RNAs “can be reverse transcribed in human cells,” “these DNA sequences can be integrated into the cell genome and subsequently be transcribed” (a phenomenon called “retro-integration”) — and there are viable cellular pathways to explain how this happens. According to Ph.D. biochemist and molecular biologist Dr. Doug Corrigan, these important findings (which run contrary to “current biological dogma”) belong to the category of “Things We Were Absolutely and Unequivocally Certain Couldn’t Happen Which Actually Happened.” The findings of the Harvard and MIT researchers also put the CDC’s assumptions about mRNA vaccines on shakier ground, according to Corrigan. In fact, a month before the Harvard-MIT preprint appeared, Corrigan had already written a blog outlining possible mechanisms and pathways whereby mRNA vaccines could produce the identical phenomenon. In a second blog post, written after the preprint came out, Corrigan emphasized that the Harvard-MIT findings about coronavirus RNA have major implications for mRNA vaccines — a fact he describes as “the big elephant in the room.” While not claiming that vaccine RNA will necessarily behave in the same way as coronavirus RNA — that is, permanently altering genomic DNA — Corrigan believes that the possibility exists and deserves close scrutiny. In Corrigan’s view, the preprint’s contribution is that it “validates that this is at least plausible, and most likely probable.”
Reverse transcription
As the phrase “reverse transcription” implies, the DNA-to-mRNA pathway is not always a one-way street. Enzymes called reverse transcriptases can also convert RNA into DNA, allowing the latter to be integrated into the DNA in the cell nucleus. Nor is reverse transcription uncommon. Geneticists report that “Over 40% of mammalian genomes comprise the products of reverse transcription.” The preliminary evidence cited by the Harvard-MIT researchers indicates that endogenous reverse transcriptase enzymes may facilitate reverse transcription of coronavirus RNAs and trigger their integration into the human genome. The authors suggest that while the clinical consequences require further study, detrimental effects are a distinct possibility and — depending on the integrated viral fragments’ “insertion sites in the human genome” and an individual’s underlying health status — could include “a more severe immune response … such as a ‘cytokine storm’ or auto-immune reactions.” In 2012, a study suggested that viral genome integration could “lead to drastic consequences for the host cell, including gene disruption, insertional mutagenesis and cell death.” Corrigan makes a point of saying that the pathways hypothesized to facilitate retro-integration of viral — or vaccine — RNA into DNA “are not unknown to people who understand molecular biology at a deeper level.” Even so, the preprint’s discussion of reverse transcription and genome integration elicited a maelstrom of negative comments from readers unwilling to rethink biological dogma, some of whom even advocated for retraction (though preprints are, by definition, unpublished) on the grounds that “conspiracy theorists … will take this paper to ‘proof’ that mRNA vaccines can in fact alter your genetic code.” More thoughtful readers agreed with Corrigan that the paper raises important questions. For example, one reader stated that confirmatory evidence is lacking “to show that the spike protein only is expressed for a short amount of time (say 1-3 days) after vaccination,” adding, “We think that this is the case, but there is no evidence for that.” In fact, just how long the vaccines’ synthetic mRNA — and thus the instructions for cells to keep manufacturing spike protein — persist inside the cells is an open question. Ordinarily, RNA is a “notoriously fragile” and unstable molecule. According to scientists, “this fragility is true of the mRNA of any living thing, whether it belongs to a plant, bacteria, virus or human.” But the synthetic mRNA in the COVID vaccines is a different story. In fact, the step that ultimately allowed scientists and vaccine manufacturers to resolve their decades-long mRNA vaccine impasse was when they figured out how to chemically modify mRNA to increase its stability and longevity — in other words, produce RNA “that hangs around in the cell much longer than viral RNA, or even RNA that our cell normally produces for normal protein production.” It is anyone’s guess what the synthetic mRNA is doing while it is “hanging around,” but Corrigan speculates that its enhanced longevity raises the probability of it “being converted over into DNA.” Moreover, because the vaccine mRNA is also engineered to be more efficient at being translated into protein, “negative effects could be more frequent and more pronounced with the vaccine when compared to the natural virus.”
Dollar signs
Corrigan acknowledges that some people may dismiss his warnings, saying “If the virus is able to accomplish this, then why should I care if the vaccine does the same thing?” He has a ready and compelling response:
“There’s a big difference between the scenario where people randomly, and unwittingly, have their genetics monkeyed with because they were exposed to the coronavirus, and the scenario where we willfully vaccinate billions of people while telling them this isn’t happening.”

Unfortunately, the prevailing attitude seems to be that the “race to get the public vaccinated” justifies taking these extra risks. In mid-November, after the Jerusalem Post told readers that “when the world begins inoculating itself with these completely new and revolutionary vaccines, it will know virtually nothing about their long-term effects,” an Israeli hospital director argued that it’s not worth waiting two more years to ferret out mRNA vaccines’ “unique and unknown risks” or potential long-term effects. In the U.S., enthusiasm for mRNA technology is similarly unfettered. Just a few days after the CDC released updated data showing that more than 2,200 deaths of individuals who had received either the Pfizer or Moderna mRNA vaccines had been reported as of Mar. 26 , The Atlantic praised the technology, suggesting that the “ingenious” synthetic mRNA technology behind Pfizer’s and Moderna’s COVID vaccines represented a “breakthrough” that could “change the world.” Rather than dismiss the prospect of retro-integration of foreign DNA as a “conspiracy theory,” scientists should be conducting studies with the mRNA-vaccinated to assess actual risks. For example, Corrigan believes that while in vitro data in human cell lines (one of the data sources examined by the Harvard-MIT researchers) offer “air tight” results, there is still a need to conclusively demonstrate real-life genomic alteration through “PCR, DNA sequencing or Southern Blot … on purified genomic DNA of COVID-19 patients” — and vaccinated individuals. Yet instead of addressing these research gaps, companies are salivating over the potential to use human-edited mRNA to “commandeer our cellular machinery” and “make just about any protein under the sun.” A March 10 press release pronouncing mRNA vaccines the clear winners of the COVID-19 vaccine race noted that all major pharmaceutical companies are now “testing out the [mRNA] technology by entering into license agreements and/or collaboration with well-established RNA companies.”

scrooge-mcduck.png
scrooge-mcduck.png (103.21 KiB) Viewed 15 times

In old Disney cartoons, viewers often witnessed Donald Duck’s rich uncle, Scrooge McDuck’s, “bulging eyes [turn] into oversized Vegas slot machine dollar signs” when contemplating opportunities to increase his already immense wealth. Judging by pharmaceutical company executives’ willingness to overlook mRNA vaccines’ long-term — and possibly multigenerational — risks, they must be similarly entranced by dollar-sign visions of a never-ending pipeline of “plug and play” mRNA products.
--
PDF: SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome



Scientists Warn Pfizer, Moderna Vaccines May Cause Blood Clots, Too
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... ood-clots/
Category: healthNews
Published: April 16, 2021

Description: The Johnson & Johnson and AstraZeneca COVID vaccines are under the microscope for their potential to cause blood clots, but scientists warn Pfizer and Moderna vaccines pose similar risks. U.S. and European health officials are scrutinizing the Johnson & Johnson (J&J) and AstraZeneca COVID vaccines for possibly causing blood clots and related blood disorders in vaccine recipients. But evidence is mounting that the Pfizer and Moderna vaccines cause similar adverse reactions — and U.S. regulatory officials were alerted to that fact as far back as December 2020. The Centers for Disease Control and Prevention (CDC) on Wednesday convened an emergency meeting of its Advisory Committee on Immunization Practices (ACIP) to determine whether to lift a ban on the J&J vaccine. The ban was put in place Tuesday, after reports of blood clots. During the meeting, committee members hailed the Pfizer and Moderna mRNA vaccines as great alternatives to the J&J vaccine because there were “no safety signals” — suggesting, unlike the J&J and AstraZeneca adenovirus-based vaccines, mRNA vaccines are not associated with blood clots. On Tuesday, Peter Marks, director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration (FDA), said on a call with reporters there had been no reported cases of cerebral venous sinus thrombosis (CVST) with thrombocytopenia (low blood platelets that can cause dangerous internal bleeding) following Pfizer and Moderna vaccines. But Mark’s statement contradicts numerous news reports, recent studies and even a scientist’s warning directed specifically to Marks late last year — it also contradicts data from the Vaccine Adverse Event Reporting System (VAERS). Utilizing a search criteria that included reports of blood clots associated with blood coagulation disorders, VAERS yielded a total of 795 reports for all three vaccines from Dec. 14, 2020 through April 1, 2021. Of the 795 cases reported, there were 400 reports attributed to Pfizer, 337 reports with Moderna and 56 reports with J&J — far more than the eight cases under investigation, including the two additional cases added Wednesday.
Study released today links Pfizer, Moderna to blood clots
A study released today by Oxford University found the number of people who developed CVST blood clots after COVID vaccines was about the same for Pfizer, Moderna and AstraZeneca, MarketWatch reported. (J&J is not approved for use in the EU, where the study originated). According to the study, 4 in 1 million people experienced CVST during the two weeks following vaccination with the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. Although researchers found a significantly higher incidence of blood clots in people who were infected with COVID, the incidence of blood clots following vaccines was still much higher than the background incidence of 0.41, a strong signal that the vaccines pose this specific risk. “These findings are consistent with what we know about how vaccine-induced spike proteins can on their own cause cell signaling through interactions with the ACE-2 receptors,” said Lyn Redwood, RN, MSN, president emerita of Children’s Health Defense. “When this happens, it can result in inflammation and a host of other potentially pathological events in the epithelial lining of the blood vessels which can then trigger pro-inflammatory cytokines capable of activating coagulation systems and down-regulating anticoagulant pathways resulting in clot formation.” A study published February in the Journal of Hematology examined thrombocytopenia following Pfizer and Moderna vaccination in response to the death of a 56-year-old Florida physician — the first identified patient who died from a brain hemorrhage after receiving Pfizer’s vaccine. Researchers examined 20 case reports of patients with immune thrombocytopenia (ITP) following vaccination, including 17 without pre‐existing thrombocytopenia using data from the CDC, FDA, U.S. Department of Health and Human Services, Vaccine Adverse Events Reporting System (VAERS), published reports, and communications with patients and treating providers. After analyzing data researchers could not exclude the possibility that the Pfizer and Moderna vaccines had the potential to trigger ITP and recommended additional surveillance to determine the incidence of thrombocytopenia post vaccination. “While the main concern associated with ITP is bleeding, it may come as a surprise that ITP is also associated with a 20% increased risk for blood clots,” Redwood said, pointing to a March 8 article by Dr. Robert Bird, director of haematology at Princess Alexandra Hospital in Brisbane, Australia.
Physicians weigh in on how vaccines might lead to blood clots
The Association of American Physicians and Surgeons (AAPS) said in an April 5 press release all three vaccines approved for emergency use in the U.S. (Pfizer, Moderna and J&J) cause human cells to manufacture the spike protein, which then induces the immune system to make antibodies to that protein. When a vaccinated person is then exposed to the virus, the immune system will recognize the threat and mount a defense that should at least minimize symptoms. The spike protein is just a fragment of a virus, so it — or the mRNA that codes for it — cannot cause an infection. However, there are questions about whether the spike protein itself can cause harm as it binds to tissue receptors, AAPS explained. AAPS physicians and scientists informed the FDA that mRNA products, through spike proteins, may have “the potential to cause microvascular injury [inflammation and small blood clots called microthrombi] to the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.”The FDA has not responded. At least 37 people have developed a rare platelet disorder after receiving the Pfizer or Moderna shot, including 56-year-old Florida obstetrician Gregory Michael who developed the disorder three days after receiving the Pfizer product and died 15 days after being vaccinated, AAPS said. On April 13, Dr. Hooman Noorchashm, a physician-scientist and advocate for ethics who specializes in cardiothoracic surgery, joined Tucker Carlson on his show to discuss blood clots and vaccines. Noorchashm explained that although it’s a good sign the FDA is taking blood clot complications with J&J seriously, it is missing similar thrombotic complications with Pfizer and Moderna. “I don’t know why this cluster is sort of affecting J&J. There are certainly other examples of thrombotic events with Pfizer and Moderna that have been entered into the VAERS system,” Noorchashm said.
Scientist warned FDA in December about COVID vaccines and blood clots
On Dec. 8, 2020, before any COVID vaccines received Emergency Use Authorization in the U.S., J. Patrick Whelan, M.D., Ph.D., wrote the FDA about the potential for vaccines designed to create immunity to the SARS-CoV-2 spike protein “to cause microvascular injury and blood clots throughout the body including the brain, heart, liver and kidneys in ways that were not assessed in the safety trials.” As The Defender reported in February, Whelan, a Harvard-trained physician with a background in biochemistry, medicine and rheumatology, did not dispute the vaccines’ potential to quickly arrest the spread of the virus — assuming the vaccines prove to actually prevent transmission, which also was not assessed in the clinical trials. But Whelan cautioned that “it would be vastly worse if hundreds of millions of people were to suffer long-lasting or even permanent damage to their brain or heart microvasculature as a result of failing to appreciate in the short-term an unintended effect of full-length spike protein-based vaccines on other organs.” The J&J vaccine was paused because six women in the U.S. developed a rare and serious disorder called cerebral venous thrombosis which occurs when a blood clot forms in the brain’s venous sinuses. The clot prevents blood from draining out of the brain. As a result, blood cells may break and leak blood into the brain tissues, forming a hemorrhage. According to Redwood, cerebral venous thrombosis has also been reported in cases of COVID-19 infections. She explained how the same condition that can occur in someone infected with the virus might also occur in someone who gets a COVID vaccine. “The science has progressed rapidly and we are now aware that the spike protein alone, without COVID infection, is capable of traveling through the body and binding to ACE-2 receptors and activating a host of cell-signaling pathways capable of triggering a wide range of adverse events,” Redwood said. A landmark study in Nature Neuroscience documented that commercially obtained COVID-19 spike protein (S1) injected into mice not only crossed the blood-brain barrier into the brain, but also the lung, spleen, kidney and liver of the mice. A second study published in Neurobiology of Disease reported that the SARS-CoV-2 spike protein alone, without the virus, is a potent inductor of endothelial dysfunction through interaction with ACE-2 receptors resulting in a pro-inflammatory response in the vessel linings. The endothelium is a thin membrane that lines the blood vessels that control vascular relaxation and contraction as well as enzymes that control blood clotting, immune function and platelet adhesion. Following vascular injury that can be caused by inflammation generated by spike proteins the endothelium shifts to a pro-thrombotic/pro-coagulant phenotype resulting in blood clot formation and other untoward events. According to Redwood, it’s “only logical to assume” that when the vaccine creates the identical spike protein that occurs in infection, and which has been identified as the culprit causing a myriad serious and life threatening injuries, “we are going to see these same injuries in individuals who receive the vaccines.” Redwood said it’s critical that we thoroughly research these vaccine-related injuries before we resume vaccination with spike protein vaccines, especially in children where we have no real data on safety and effectiveness.
--
PDF: Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine
--
PDF: The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice
--
PDF: The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier



Denmark Ditches J&J COVID Vaccine, Says Benefits ‘Do Not Outweigh Risk’ of Blood Clots
Children's Health Defense

URL: https://childrenshealthdefense.org/defe ... d-vaccine/
Category: healthNews
Published: May 3, 2021

Description: The Danish Health Authority today said it won’t use the Johnson & Johnson shot, citing a possible link to blood clots. The move follows the decision last month to dump AstraZeneca’s vaccine over similar concerns.



Denmark on Monday became the first country to exclude Johnson & Johnson’s (J&J) COVID vaccine from its vaccination program over a potential link to blood clotting disorders.The Danish Health Authority said in a statement it had concluded “the benefits of using the COVID-19 vaccine from J&J do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine,” Reuters reported. Danish health officials noted the European Medicines Agency’s (EMA) conclusion that “there is a possible link between rare but severe cases of blood clots and the COVID-19 vaccine from J&J,” referring to an investigation last month into eight U.S. reports of rare blood clots — one of which was fatal — that occurred after recent vaccination. Unlike the Danish Health Authority however, the EMA concluded the benefits of using the J&J vaccine outweigh the risks. The EMA did recommend adding a warning to J&J’s vaccine label, and the company said it would comply with that measure. “Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from COVID-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate,” the health authority said. Denmark stopped using AstraZeneca’s vaccine last month after European regulators found a possible link between AstraZeneca’s COVID vaccine and “very rare” blood clots. Both J&J and AstraZeneca vaccines use a modified adenovirus vector technology as opposed to the mRNA technology used in the Moderna and Pfizer’s COVID vaccines. The EMA noted in its findings on the J&J vaccine that one plausible explanation for the combination of blood clots and low blood platelets could be an immune response leading to a condition similar to heparin-induced thrombocytopenia. Scientists in Norway and Germany who studied blood clots after vaccination with AstraZeneca suggested some people may experience an abnormal immune response causing them to form antibodies that attack their own platelets after being vaccinated. It’s not yet clear if there might be a similar mechanism with the J&J vaccine, but J&J and AstraZeneca vaccines, as well as Russia’s COVID vaccine and China’s, are made with the same technology. On April 13, the Centers for Disease Control and Prevent (CDC) and the U.S. Food and Drug Administration (FDA) called for an immediate halt to the use of J&J’s COVID vaccine, marketed under the company’s Janssen subsidiary, while they investigated at least six cases of potentially dangerous blood clots in people who received the vaccine. All six occurred in women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination. One death was reported. As The Defender reported, one of the six cases included a Nevada teen who underwent three brain surgeries to repair blood clots she developed about a week after being vaccinated. On April 14, the CDC’s Advisory Committee on Immunization Practices (ACIP) postponed a vote on whether to lift the pause on the J&J vaccine, effectively extending the pause pending further analysis of data relating to blood clots in people who received the vaccine. That same day, J&J revealed two more cases of blood clots — one in a 25-year-old man who suffered a cerebral hemorrhage during a clinical trial and another case of deep-vein-thrombosis in a 59-year-old woman. On April 23, the ACIP voted 10 – 4 to lift the pause and continue use of the J&J shot without restrictions or an additional warning about the risk of blood clotting disorders after analyzing 15 cases of rare blood clots, including three deaths, according to a slide presentation shared during the meeting. The ACIP said the link between blood clots and J&J’s COVID vaccine was “plausible,” but concluded the vaccine’s benefits outweigh the risks and recommended the vaccine for persons 18 years of age and older in the U.S. under the FDA’s Emergency Use Authorization (EUA). Children’s Health Defense queried the VAERS data for a series of adverse events associated with the formation of clotting disorders and other related conditions. VAERS yielded a total of 1,845 reports for all three vaccines from Dec. 14, 2020, through April 23. Of the 1,845 cases reported, there were 655 reports attributed to Pfizer, 577 reports to Moderna and 608 reports to J&J. U.S. health officials only acknowledged 15 blood clot cases associated with the J&J vaccine at the April 16 meeting. Though J&J and AstraZeneca vaccines have been under the microscope for their potential to cause blood clots, scientists warned, as far back as December 2020, that mRNA vaccines like Pfizer and Moderna pose similar risks.
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

Deception Surrounds COVID, Vaccines & More: Dr. Fleming

Postby smix » Tue Feb 16, 2021 4:36 pm

Deception Surrounds COVID, Vaccines & More: Dr. Fleming
The New American

URL: https://thenewamerican.com/deception-su ... r-fleming/
Category: healthNews
Published: February 9, 2021

Description: In this explosive interview with The New American magazine’s Alex Newman, Dr. Richard Fleming explains that there is an enormous amount of deception surrounding COVID19, treatments, and the so-called vaccines. Dr. Fleming, who is a PhD in physics as well as a medical doctor and even has a law degree, argues that there is much evidence suggesting that the SARS-Cov-2 virus was created in a laboratory through U.S. taxpayer-funded “gain of function” research by scientists in America and Wuhan, China. He even names names. He also explains a great deal about the mRNA technology at the core of the COVID vaccines, which he warned is experimental and is not even approved by the FDA. Pointing to the “Emergency Use Authorization,” Dr. Fleming said people are being misled, and that authorities and medical professionals are failing to obtain “informed consent” before using the experimental vaccines on people. The doctor and expert in so many fields concludes by recalling the horrors perpetrated by Nazi medical professionals, warning doctors and policymakers to be very careful.



Documentation and additional material regarding the information shared and claims made in this interview by Dr. Fleming can be found at his website: FlemingMethod.com



COVID Shots to “Decimate World Population,” Warns Dr. Bhakdi
The New American

URL: https://thenewamerican.com/covid-shots- ... dr-bhakdi/
Category: healthNews
Published: April 16, 2021

Description: In this exclusive interview with The New American magazine’s Senior Editor Alex Newman, world-renown German-Thai-American microbiologist Dr. Sucharit Bhakdi warns that the COVID hysteria is based on lies and that the COVID “vaccines” are set to cause a global catastrophe and a decimation of the human population. Starting off, he explains that the PCR test has been abused to produce fear in a way that is unscientific. Next, he explains what the mRNA vaccines are going to do to the human body in terms and using analogies that anyone can understand. Among other concerns, he expects massive deadly clotting as well as immune system responses that will destroy the human body. Finally, Bhakdi, who warned of impending “doom” during a Fox News interview that went viral, calls for criminal prosecutions of the people responsible and an immediate halt to this global experiment.





Genetic Vaccines: Are They the New Thalidomide?
The New American

URL: https://thenewamerican.com/genetic-vacc ... alidomide/
Category: healthNews
Published: April 19, 2021

Description: Many Americans have heard the news account of Dr. Gregory Michael, a 56-year-old Florida physician who, after receiving his first dose of a Pfizer COVID vaccine on December 18 of last year, was hospitalized three days later. He had a total loss of his platelets — the little blood cells that stop bleeding. In spite of being treated by a team of physicians, he died two weeks later from a brain hemorrhage, and was reported to have had zero platelets. By February 10, 2021, 36 other similar cases were reported in the mainstream media. Pfizer, which along with its partner BioNTech made the vaccine the doctor received, said in a statement that it was aware of the death. Typically, they concluded, “We are actively investigating this case, but we don’t believe at this time that there is any direct connection to the vaccine.” Pfizer made this “finding” despite several unusual circumstances of the case. First, low-platelet disorders, known as idiopathic thrombocytopenic purpura (ITP), most commonly affect children, and generally follow a viral illness. Only 10 percent of ITP cases occur in adults, who usually present with a slow onset form of the disorder, referred to as chronic ITP. The disorder usually starts by someone noticing easy bleeding, such as slow oozing from gums or the nose, or bruises showing up without trauma. Rarely do platelets drop below 20,000, and generally treatment either reverses the disease or prolongs life for years in spite of the problem. What happened to this physician and the others seems to be a new previously unseen problem related to vaccination — despite the manufacturers’ claims. Increasingly, vaccine manufacturers and government officials are following the sarcastic maxim from Samuel Shem’s novel of medical residency entitled The House of God that “if you don’t take a temperature you can’t find a fever.” In other words, if we don’t critically look at the actual recorded patient damage, we won’t find our products to be defective. Now, major media are increasingly getting on board, condemning “vaccine hesitancy” and pushing everyone to get vaccinated for COVID, discounting any dangers. But in the practice of medicine, we are supposed to employ the “precautionary principle” — above all do no harm. Moderna and Pfizer COVID-19 “vaccines” are experimental, employing a genetic technology never before used on humans. Ironically, many people who wouldn’t purchase the first edition of a new car line are lining up to take an injection they know nothing about, that has never successfully passed animal trials, that could never meet the required “safety level” for a “drug,” and is unapproved for the prevention of COVID except as an emergency experiment. Legally, those who get the vaccine are unnamed participants in a Stage IV FDA trial. Moreover, a vaccine is supposed to prevent disease. By that definition, these agents are not even vaccines. They are more properly termed “experimental unapproved genetic agents.” By admission of the manufacturers themselves, both the Pfizer and Moderna products only lessen the symptoms of COVID; they don’t prevent transmission. Vaccination was first invented to treat smallpox, which had a a fatality rate of up to 60 percent. Then other diseases such as typhoid and polio were similarly addressed. But vaccination is not used when effective safe treatment is available. Although censorship has confused the public understanding, overwhelming evidence dating back to the 1970s shows that viruses can be treated with “lysosomotropic agents.” The truth is, hundreds of papers have shown that chloroquine, and its later version hydroxychloroquine, are very effective in treating this virus if given early. A worldwide open architecture online review of COVID survival (hcqtrial.com) showed that death rate was 78.7-percent lower in those countries where hydroxychloroquine was used early and often:

Screen-Shot-2021-04-16-at-2.58.00-PM.png

Multiple large studies done in outpatient settings show very excellent prevention and cure with these and other drugs such as Ivermectin. In Mumbai, India, a study was done of the city police force of 10,000 officers. No deaths were recorded in the 4,600 officers taking a small dose of hydroxychloroquine each week. All the deaths were in the untreated group. Using Worldometer statistics, COVID deaths per capita in New York State are 2,656 per million population; in New Jersey they are 2,821 per million population. In India the rate is 126 per million and in Uganda it is only seven per million. Neither India nor Uganda used social distancing in any real way. But they do use hydroxychloroquine. New York (except for Dr. Zev Zelenko and a few others) does not use the drug. As to the claims of the efficacy of the drugs, the declaration of 95-percent effectiveness of the Pfizer product was shown to be bunkum by Dr. Peter Doshi, the associate editor of the British Medical Journal, writing in that publication. After doing an independent review of the data submitted to the FDA, Dr. Doshi reported that only 30 percent of test subjects, at best, experienced even the slightest benefit (symptom reduction). Absolute risk reduction — in other words stopping transmission — he estimated at less than one percent. The limited benefit of taking the drugs is made worse by the relatively high death tolls from the new mRNA therapy. During the first two months of the rollout of Pfizer and Moderna “vaccines” in 2021, 95 percent of deaths from vaccines recorded in the Vaccine Adverse Event Reporting System (VAERS) were for those agents, meaning only five percent of reported deaths involved all the other vaccines put together. Compared to 2019, deaths in VAERS are up 6,000 percent. Thirty-six deaths were recorded in the first quarter of 2020 versus 1,754 in the first quarter of 2021. In Israel, where the Pfizer mRNA product is being used exclusively and a major push is on to vaccinate the whole population, an independent review of government data after two months of the vaccine program was done by the Aix-Marseille University Faculty of Medicine Emerging Infectious and Tropical Diseases Unit’s Dr. Hervé Seligmann and engineer Haim Yativ. They showed that when 12.5 percent of Israelis were vaccinated, 51 percent of the deaths from COVID were in the vaccinated group. Additionally, in the over 65-year-olds, vaccination resulted in death from COVID 40 times more than in unvaccinated people. In other words, this is not protecting people from COVID but increasing fatalities from the disease — and this neglects the number of other side effects. If the truth were known, most sane, thinking people would not likely take part in such an experiment. With the truth hidden and with threats of travel bans and an unwarranted fear of COVID, and with pressure from employers and the politicization of COVID in general, Americans have been throwing caution to the wind.
The Unknowns
To understand what is actually happening to people after receiving the mRNA agents, I reviewed data in VAERS — an open-source searchable database of possible vaccine side effects reported by both providers and patients. According to the CDC website:
VAERS is used to detect possible safety problems — called “signals” — that may be related to vaccination. If a vaccine safety signal is identified through VAERS, scientists may conduct further studies to find out if the signal represents an actual risk.

The main goals of VAERS are to:
* Detect new, unusual, or rare adverse events that happen after vaccination.
* Monitor increases in known side effects, like arm soreness where a shot was given
* Identify potential patient risk factors for particular types of health problems related to vaccines
* Assess the safety of newly licensed vaccines
* Watch for unexpected or unusual patterns in adverse event reports
* Serve as a monitoring system in public health emergencies

The CDC acknowledges limitations of the system, including:
* Reports submitted to VAERS often lack details and sometimes contain errors.
* Serious adverse events are more likely to be reported than mild side effects.
* It is generally not possible to find out from VAERS data if a vaccine caused the adverse event.

I searched the VAERS database using keywords that would identify bleeding problems and thrombocytopenia (low or absent platelets). Entries are defined by age groups and sex with a narrative account of the injury. In a two-and-a-half-month period from December 15, 2020 to March 12, 2021, 358 cases of unusual clotting or bleeding were identified, and it makes grim reading. There were 104 cases of frank thrombocytopenia (low platelets) — some including young people. However, the numbers alone do not adequately convey the problems. In one case about an 18-29 year-old female, the physician wrote this: “Patient was seen in in my office on 1/19/21 with complaint of heavy vaginal bleeding. A CBC was obtained which revealed an H/H of 12.2/36.1 and a platelet count of 1 (not 1K, but 1 platelet!) This was confirmed on smear review.” The surprise and horror the doctor experienced upon seeing the absence of platelets is clear when reading the report. But the platelet problem may just be the most severe expression of a physical derangement that is producing bleeding of all sorts. As seen in the table below, there were 49 people with brain hemorrhages — nine fatal at the time of reporting. A number of other people arrived at Emergency Departments with bleeding from multiple sites, or internally, so massive that they could not be stabilized even to clearly define the sources of the bleeding.

Severe Thrombocytopenia                   94
Mild Thrombocytopenia 11
Thrombocytopenic Petechial rash/bruising `5
Severe Pancytopenia 2
Unknown Hematologic Problem 1
Multifocal or “massive” brain hemorrhage 20
Focal brain hemorrhage 29
GI Bleed 34
Severe Vaginal Bleeding 7
Vaginal Bleeding 21
Bleeding in Pregnancy 6
Bleeding with Miscarriage 12
Irreg Menses 4
Oral bleeding 8
Subconjunctival Hemorrhage 11
Intraocular bleed 4
Various Spontaneous Skin bleeding 10
Vein bleeding from temple 1
Prolonged surgical site bleeding 3
Severe multifocal bleeding 5
Severe internal bleeding 5
Severe uncharacterized bleeding 3
Bleeding from cancer site liver 1
Renal dialysis shunt 1
Hematuria 2
Renal bleed 1
Tonsillar bleed 1
Acute Uterine Fibroid hemorrhage 1
Nosebleed 32
Spontaneous Splenic hemorrhage 1
Injection Site Bleeding 21
Arm Bruising 1

Most cases of severe problems were in people over the age of 50 years. But there were many younger people involved, especially in the less severe-but-unusual bleeding problems. Of the 36 reported nosebleeds, six were either unable to be stopped with usual measures, were recurrent, or were recorded as having significant blood loss or dubbed “profuse.” Many were associated with other symptoms: photophobia (eye sensitivity to light), headache, hives, “sick in bed,” brain fog, and face swelling. The youngest patient with a nosebleed was, sadly, a toddler requiring emergency care. Unusual skin bleeding was also reported. Four 65-plus-year-old males reported blood spontaneously oozing through the skin: one from the legs, one from the scalp, one from an old biopsy site, and one from an old healed “boil” site. Frank bleeding at the time of the inoculation occurred 14 times. Some bleeding was momentary, but often the bleeding was difficult to stop, recurrent, and/or persisted after the patient returned home. (How many times have you had an injection and bled at all, let alone bled off and on for hours?) Perhaps the saddest were the bleeding episodes that preceded spontaneous miscarriages. Here are some direct entries in VAERS:
40-49 y.o. Female: The evening of my vaccination I began to feel feverish, weak and achy. During the night I woke with heavy bleeding and found out the following morning I had miscarried my otherwise healthy pregnancy.
39 y.o. Female: Internal brain bleeding 10 days after 1st dose Covid vaccine; brain damage, confused, suffering memory loss; This is a spontaneous report from a contactable physician (patient).
30-39 y.o. Female: 48 hours after injection developed micro-hemorrhages in her right eye. Symptoms resolved and 12/29 recurrence of bleeding to right eye slightly worse than before
65+ y.o. Male: Patient developed significant nose bleed after receiving vaccine. Required emergency department visits x 2 and hospitalization.
65+ y.o. Female: Vaccine administered 02/02/2021. By Thursday 2/11/2021 patient almost nonverbal, by Monday 2/15/2021 patient went to the hospital with bruising, sores on her stomach and clots reported as thrombocytopenia. Deceased by Friday, 2/19/20201.
40-49 y.o. Female: Bleeding, myalgia, tingling in the fingers of the right hand; fatigue immediately upon vaccination — bleeding at the injection site which the employee reports as filling the Band-Aid over the site. When she got home in the evening and took it off blood ran.
65+ y.o. Female: Within 15 min of the injection, the individual became aphasic and stroke like symptoms. She was taken to the ER where she was later diagnosed with a cerebral hemorrhage and passed away.

When such facts are presented, the standard retort from vaccine advocates is, “We have given millions of vaccines, so a few deaths are to be expected.” Besides the fact that a willingness to sacrifice individuals for the nebulous good of the masses represents a bankrupt moral order, simply calculating the numbers of deaths is inadequate. “Experts” need to take the time to read the narrative to open their eyes — and their hearts — to the suffering happening. There are over 25 pages of such stories printed from VAERS entries, and we must consider, “How many of these people are now dead, and how many are going to die?” A second-year medical student armed with the facts should recognize looming disaster — where are the experts? In truth, neither recipients nor their doctors know what is in these “vaccines.” Only a few people at the top of the Moderna, Pfizer, Johnson & Johnson, and AstraZeneca research groups really understand them. These mRNA injections produce a potentially deadly pathogen — the spike protein — in your cells. The Emergency Use Authorization for the Pfizer product says that it contains “a nucleoside-modified messenger RNA (modRNA) encoding the viral spike glycoprotein (S) of SARS-CoV-2.” If your immune system is strong enough to withstand this onslaught and create some immunity, you may survive the first onslaught. But even if you don’t die in the short term, mRNA is an epigenetic controller of DNA. Though this foreign synthetic mRNA doesn’t actually become part of your DNA to make you a “GMO human,” as some people have been worrying about, it can control DNA in ways we have yet to completely understand. We literally have no idea whether this bodily additive is going to have a side effect of expressing cancer genes, or of repressing cancer protective genes, or thousands of other potentially deadly unknowns. Additionally, the Pfizer vaccine includes all types of ingredients that may by themselves create ailments. The Pfizer shot contains “lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2- hexyldecanoate), 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-distearoyl-snglycero-3-phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.” I insert this list just for completeness — don’t expect to make sense of it. Your doctor can’t either. I understand “sucrose” (sugar) and sodium chloride (salt), but who doesn’t get lost in the “hydroxybutyl” and “distearoyl” lipid list? After doing some sleuthing and having some inside knowledge to start from, I discovered that this lipid particle is an adjuvant called “Matrix M.” As described in scientific literature, “Adjuvant Matrix-M™ is comprised of 40 nm nanoparticles composed of Quillaja saponins, cholesterol and phospholipid.” Matrix-M essentially wraps the mRNA in a lipid coating that allows it to move through cell walls and to linger in your system. Matrix-M is derived from plant chemicals called saponins, which have poorly understood properties in plant biology. They can be toxic to humans in some cases, and have been traditionally used by aboriginal tribesmen to poison fish. Should we consider that comforting? The pharmacology industry has a long history of removing bad drugs from the market. Thalidomide is perhaps the most famous example of a pharmacologic disaster. The drug was released in 1957 for its sedative effects and was touted as being safe for everyone including “pregnant women and children.” In 1961, Dr. William McBride, an obstetrician, discovered that thalidomide was useful for “morning sickness” in pregnant women. Later he began to see unusual and devastating birth defects in babies born to women for whom he had prescribed the drug. Independently, Dr. Widuking Lenz, a pediatrician in Germany, also associated thalidomide with severe and unusual birth defects, such as the absence of limbs or parts of limbs. Sometimes an infants’ hands were attached at the shoulders, there being no connecting long bones at all. By 1962 the drug was taken off the market. But unlike with our new, experimental agents, recognition of the thalidomide problem was made relatively easy by several factors. First among these was the uniqueness of the deformities. These were both profound and obvious, which stand in stark contrast to the current bleeding problems, which appear on the surface to be normal problems in clinical medicine — such as nosebleeds. Even now, doctors continue to call the loss of platelets “ITP” — even though what we are seeing is not the same as what we would expect to see under that diagnosis. ITP simply does not kill adult males in a few days. Second, with thalidomide, the physician who first began using the drug for nausea in pregnancy was also the doctor who delivered the affected babies, so he could readily put two and two together. In the case of our COVID drugs, when your doctor tells you to get a vaccine, he doesn’t administer it, doesn’t witness the injection, and usually doesn’t follow up to see how you fared. And if you were to suddenly develop a vision problem or bleeding from the bowel, you wouldn’t be seen by your PCP; you would be in an Emergency Department — and they don’t usually ask about your recent vaccine history. Third, Dr. Lenz presciently recognized that, in the case of thalidomide, many less-severe deformities, when put into perspective, revealed “gradations of the defect.” Unfortunately in the present case, lesser degrees of clotting problems are indistinguishable from bleeding issues frequently encountered in an Emergency Room or doctor’s office. For example, if a 75-year-old hypertensive male — who has gotten a COVID shot — suffers a brain hemorrhage and dies, it would not likely be deemed unusual, and the relationship to vaccination may not even be explored. Keeping that in mind, we should assume the worst when it comes to these new COVID shots. When any new drug problem starts, it begins slowly and unrecognized — like a snowball beginning to roll down a mountain. By the time the problem is generally acknowledged, the avalanche is well on its way. In the case of thalidomide, over 100,000 children were severely damaged before the drug was removed from use. Though VAERS has the potential to shorten recognition time of drug problems by trying to spot the “unusual patterns,” this requires that physicians be aware of the system, and take the time to enter any suspected side effects — not just the worst cases. It also requires that researchers care enough to look. This is not happening. A report previously submitted to the Agency for Healthcare Research and Quality revealed that fewer than one percent of adverse events get reported to VAERS. In the past, testing done on mRNA technology revealed problems specifically involving the clotting system. Antibody-mediated platelet damage has been suspected. Yet today when these exact problems arise, the researchers are mum. Do the experts not study or know their own vaccine research history? For those who are concerned about the risks, we need to advocate for ourselves, either through contacting legislators or simply refusing to take the shots. It’s obvious that the pharmaceutical industry is willing to release untried technology upon the entire world population, and not be deterred by any inconvenience such as unexplained death. We need to stop being a gullible population that forces our children to get vaccinated for trivial, non-fatal diseases such as mumps. We need to stop believing in the god-like status of medical technocrats who claim to be making the world safer. We need to reject the idea that vaccine deniers are anti-scientific troglodytes. We must reject the unspoken premise under which pharmaceutical companies and doctors operate — that all vaccines are always safe in all people all the time. It should not be considered unreasonable to require scientific transparency, honesty by drug manufacturers, and safety from vaccines. Vaccines are only indicated for diseases with a high risk of death or morbidity, and for which there is no cure. After seeing the esteemed leaders in medicine denigrate hydroxychloroquine (even though it was a recognized treatment used successfully elsewhere for SARS, and mentioned favorably by Dr. Fauci for MERS), after watching three plants used in the production of hydroxychloroquine burn down in a year — two on the same day — after watching doctors lose their jobs and be censored for speaking truth and saving lives with old safe drugs that work, and now, after seeing experimental genetic agents being rolled out for use globally that have never passed animal testing and have only a few months human trials, perhaps it is time to address the 800-pound gorilla in the room and ask, “Are they trying to kill us?”



People Testing Positive for COVID-19 AFTER Getting the Vaccine
The New American

URL: https://thenewamerican.com/people-testi ... e-vaccine/
Category: healthNews
Published: April 20, 2021

Description: The Biden administration is urging American adults to “roll up their sleeves” and take the COVID shot, and doctors everywhere are being told to encourage people to take the experimental vaccine for everyone’s health and safety, yet all over the country fully vaccinated individuals are testing positive for the virus. More than 200 people in 24 different Washington counties tested positive after receiving vaccinations just last week. Of that 200, five people died. In St. Louis County, Missouri, 71 people tested positive after being fully vaccinated; and 246 people in Michigan tested positive after vaccination, and three of them died. Health officials say this is rare and uncommon, but more and more reports are coming in of people testing positive for COVID even after both doses of the vaccine. The CDC has yet to address this alarming occurrence. As if that weren’t concerning enough, any deaths resulting from the vaccine will go without compensation because of the Public Readiness and Emergency Preparedness Act (PREPA). Passed back in 2005, PREPA exempts vaccine developers from vaccine safety laws in the event of an emergency declaration (such as a “pandemic”) by Health and Human Services, and protects them from lawsuits unless “willful misconduct” can be proven. So family members of those individuals who have died from the vaccine will receive nothing from vaccine manufacturers. To make matters worse, Dr. Fauci has repeatedly told Americans that even after taking the vaccine we should not resume life as it was before. He has urged people to continue wearing masks and to social-distance after they have received the shot. This is the same “health expert” who told us we should wear two masks to protect against a virus that is not as deadly or contagious as previously predicted. So based on the Biden administration’s “top health expert,” vaccinated people have to do all the same things that unvaccinated people do, for “the greater good.” This raises a question: If those getting in line to “roll up their sleeves” can still get COVID-19, and will not be able to sue vaccine manufacturers for damages in the event of serious side effects or death, and vaccinated individuals cannot take off their masks and get back to life as usual, then what is the point of taking the experimental drug? That question remains in the minds of those with “vaccine hesitancy.”



COVID Shot Killing Large Numbers, Warns Top COVID Doc Peter McCullough
The New American

URL: https://thenewamerican.com/covid-shot-k ... ccullough/
Category: healthNews
Published: April 27, 2021

Description: In this interview with The New American magazine Senior Editor Alex Newman, the internationally renowned Dr. Peter McCullough–the doctor with the most citations in the National Library of Medicine on these topics–warned that the COVID shot was already causing thousands of deaths and tens of thousands of hospitalizations that have been recorded. And that’s just the tip of the iceberg, he warned. In normal circumstances, 50 deaths reported to VAERS would result in a drug being taken off market immediately. In the case of the COVID shots, thousands have already been reported, and yet the mass vaccination programs continue to be pushed. Dr. McCullough, a professor of medicine who developed a globally acclaimed and highly successful COVID treatment protocol, also emphasized that there have been many unnecessary deaths as a result of policy decisions made at various levels of government.





COVID Shots, DNA & Transhumanism, With Dr. Madej
The New American

URL: https://thenewamerican.com/covid-shots- ... r-madej-2/
Category: healthNews
Published: April 29, 2021

Description: In this presentation with The New American magazine’s Alex Newman, Dr. Carrie Madej explains that the elites peddling the COVID shots are also pushing transhumanism… and the two are closely related. Genetic modifications and new technologies are on the verge of changing what it means to be human, and the elites are really pushing the boundaries. Don’t miss this critically important presentation by one of the most important doctors speaking out on these issues publicly.

User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

Australian vaccine cancelled after ‘false positive’ HIV tests

Postby smix » Tue Feb 16, 2021 8:18 pm

Australian vaccine cancelled after ‘false positive’ HIV tests
Sky News

URL: https://www.skynews.com.au/details/_6215479059001
Category: healthNews
Published: December 11, 2020

Description: University of Queensland's potential coronavirus vaccine with biotech company CSL has been abandoned after multiple trial participants returned false positive HIV test results. Their vaccine was one of four which the Morrison government had entered into a deal with – marking a blow to Australia's potential pool of vaccine options. The deal was terminated days after the government was informed about the issue on Monday. By Thursday, National Cabinet decided to scrap the use of the vaccine. More than 200 participants took part in the trial with several returning the false positive HIV test results.



The University of Queensland-CSL vaccine uses a small component derived from HIV which is unable to infect people or replicate but can initiate a response in the body that can interfere in the screening process and return a false positive. A source told the Sydney Morning Herald the people were not at risk. The decision to scrap the deal was out of an abundance of caution.



People will be 'too scared' of potential vaccine using HIV proteins
Sky News

URL: https://www.skynews.com.au/details/_6215951212001
Category: healthNews
Published: December 13, 2020

Description: The Australian Financial Review’s Aaron Patrick says people are going to be "too scared" to use a potential coronavirus vaccine after finding out a University of Queensland vaccine was made using parts of a HIV protein. Mr Patrick said the people who are already “scared” of vaccines will steer clear once they find it has HIV proteins in it. “We had this world leading vaccine coming from UQ and now we find it’s coming from the HIV virus,” he told Sky News host Sharri Markson. “We’ve blown all this money on something people will be too scared to use. Fellow guest, Sky News contributor Gemma Tognini said the anti-vaccine movement and those who are just sceptical will use this at as a foothold for their beliefs. “It is causing people who have what I believe are reasonable concerns, to perhaps be more reticent than they already are.”
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

South Africa halts rollout of AstraZeneca’s Covid-19 vaccine after shot falters against variant

Postby smix » Wed Feb 17, 2021 5:41 pm

South Africa halts rollout of AstraZeneca’s Covid-19 vaccine after shot falters against variant
STAT News

URL: https://www.statnews.com/2021/02/07/sou ... t-variant/
Category: healthNews
Published: February 7, 2021

Description: South Africa is halting its rollout of the AstraZeneca-University of Oxford Covid-19 vaccine, the country’s minister of health said Sunday, following a new analysis that suggests the shot “provides minimal protection” against mild disease caused by the new coronavirus variant circulating in South Africa. Two top virologists advising the government said during a press conference that the pause was necessary. They said South Africa would institute a new process in which vaccines are initially studied in a research phase to try and determine that each vaccine reduces Covid hospitalizations in South Africa despite the widespread new variant there. “The AstraZeneca vaccine rollout needs to be put on a temporary halt while we get the clinical efficacy information in,” said Salim Abdool Karim, an epidemiologist at Columbia University and part of a commission advising the South African government. “And the way that we can do that is with the new approach to rollout.” Barry Schoub, chair of South Africa’s Ministerial Advisory Committee on vaccines, struck a similar note. “I think we just need to maybe suspend use of AstraZeneca, but investigate it more and more fully to see, can we utilize it more effectively,” he said. The news heightens concerns about B.1.351, the variant first seen in South Africa, and will also likely lead to discussions about the effectiveness of the AstraZeneca-Oxford vaccine, which is among the least expensive and most widely available of the Covid-19 vaccines that have so far been developed. In addition to AstraZeneca, the vaccine is also being made for much of the world by Serum Institute, a large Indian vaccine maker. However, the data, which were presented in detail during the livestreamed press conference, do not give clear answers. The results involve only small numbers of patients and may not be enough to draw any conclusions. The data were also submitted as a preprint and have not yet been peer-reviewed. Shabir Madhi, professor of vaccinology at the University of the Witwatersrand and chief investigator on the new study, said that before B.1.351 became common in South Africa, the vaccine was trending toward reducing mild cases of disease by 75%. But once B.1.351 became prevalent, that number dropped precipitously, and cases were reduced only 22% based on 42 cases of symptomatic Covid. Those data appear unreliable, however. They were given with confidence intervals, which propose a range of plausible outcomes. For the 22% number, those ranged from -50% to 60%, meaning that more data would be needed to be collected to trust the figure. Researchers and AstraZeneca emphasized in separate statements that the study was a small one, including only 1,765 volunteers with a median age of 31. AstraZeneca said it believes the vaccine will still protect against severe disease caused by B.1.351. The current study gives no information on whether the vaccine prevents severe disease, hospitalization, or death. AstraZeneca also said that it and Oxford have started adapting their vaccine to B.1.351, and will advance the new vaccine through development so that it is ready for delivery in the fourth quarter of the year if it is needed. This is the third vaccine, and the first approved vaccine, to show what appears to be reduced efficacy against B.1.351. Johnson & Johnson said that its vaccine, which was 66% effective overall against moderate-to-severe disease, was 57% effective against moderate-to-severe disease due to the variant. Novavax, another vaccine developer, said that its vaccine was 89% effective against mild-to-moderate disease, but in a separate trial in South Africa was 50% effective. Karim pointed out that only the Johnson & Johnson vaccine has been shown to reduce severe disease due to B.1.351. He said that when vaccines are rolled out, South Africa will now look at hospitalization rates in the first 100,000 to receive the vaccine in the hopes that this will provide information on whether the vaccine is proving effective. Madhi warned that it could be “reckless” to simply let doses of the AstraZeneca vaccine expire without giving them, given the possibility that the vaccine could reduce severe disease.



‘I was sort of stunned’: Fauci and U.S. officials say AstraZeneca released ‘outdated information’ from Covid-19 vaccine trial
STAT News

URL: https://www.statnews.com/2021/03/23/ast ... e-results/
Category: healthNews
Published: March 23, 2021

Description: U.S. health officials raised concerns early Tuesday that positive results that AstraZeneca announced Monday for its Covid-19 vaccine may have been based on “an incomplete view of the efficacy data” from a clinical trial and relied on “outdated information,” throwing another curveball in the saga of the company’s vaccine. In a statement issued soon after midnight Tuesday morning, the National Institute of Allergy and Infectious Diseases said it had been informed about the data questions by the data and safety monitoring board auditing the trial. DSMBs consist of independent medical experts who provide an extra screen of data produced from clinical trials. “We urge the company to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible,” NIAID said. In an interview Tuesday morning with STAT, Anthony Fauci, the head of the NIAID, said the DSMB raised concerns because it felt the results in a AstraZeneca press release Monday looked more favorable than more recent data from the vaccine study had shown. “I was sort of stunned,” Fauci said. “The data safety and monitoring board were concerned that the data that went into the press release by AZ was not the most accurate and up-to-date data. That is what the DSMB communicated to AZ in a rather harsh note. Having seen that letter we could not just let it go unanswered.” Asked why NIAID released its unusual statement, Fauci said, “We just felt we could not remain silent. Because if we did remain silent, we could be understandably accused of covering something up. And we definitely didn’t want to be in that position.” He added: “In my mind, it’s an unforced error by the company.” The results released Monday by AstraZeneca came from an interim analysis of a 32,000-volunteer trial through Feb. 17. In a statement Tuesday, the company said it would “immediately engage” with the DSMB “to share our primary analysis with the most up-to-date efficacy data.” The company said it planned to announce results from the primary analysis within 48 hours. “We have reviewed the preliminary assessment of the primary analysis and the results were consistent with the interim analysis,” the company said. “We are now completing the validation of the statistical analysis.” The two-paragraph statement from the NIAID opened another chapter in the path of the AstraZeneca vaccine, which was developed along with researchers from the University of Oxford. It came not even 24 hours after the company announced in a press release Monday that its vaccine was 79% effective at preventing symptomatic Covid-19 in a U.S. trial, a result that was better than expected based on earlier trials and appeared to help resolve some questions about the robustness of the vaccine. The company also said the immunization reduced severe Covid-19 and hospitalization by 100%. The results were seen as a final step before the company would apply for authorization from U.S. regulators for its shot, which is already approved in other countries. The company’s vaccine had been under scrutiny most recently after European countries paused their rollout last week over safety concerns tied to blood clots, but the European Medicines Agency subsequently said the vaccine’s benefits outweighed its risks and the campaigns restarted. Based on the trial data released Monday, AstraZeneca said the study identified no new safety concerns. A specific review found no risk of blood clots. The study also did not see a specific type of clot in blood vessels near the brain that the EMA said might be associated with the vaccine. However, this type of clot, called a cerebral venous sinus thrombosis, is so rare it might not be expected to occur in even a large clinical trial. The NIAID statement Tuesday only cited DSMB concerns about efficacy data, and did not mention safety issues. The two-dose AstraZeneca vaccine is seen as a great hope to help expand vaccine access around the world because it is less expensive than other Covid-19 vaccines and easier to manufacture and distribute than some others. It is being widely used in Europe and increasingly in Asia. But the company’s vaccine efforts have been dogged by mishaps and questions about its public announcements. Early on, the U.S. study was stopped for a month-and-a-half because of a cerebral hemorrhage in one patient that was later determined to be unrelated to the vaccine. In initial trial results announced earlier, the data seemed to suggest at one point that the second dose of the vaccine lowered its efficacy. Some of the earlier confusion stemmed from the company’s unusual strategy of pooling data from clinical trials in its analyses. The ups and downs with AstraZeneca’s vaccines have increased concerns that the public may turn away from an immunization that could help tame the Covid-19 pandemic, at a time when public health officials are urging people to get inoculated when they have a chance. Fauci said on “Good Morning America” Tuesday the frustration was that “this is very likely a very good vaccine” and that he hoped people would understand the DSMB concerns were an example of one of the many guardrails ensuring the quality of the vaccine development process. “If you look at it, the data really are quite good, but when they put it into the press release, it wasn’t completely accurate,” Fauci said. “We have to keep essentially trying as hard as we can to get people to understand there are safeguards in place.” Asked whether he was worried about people’s confidence in the AstraZeneca vaccine and others, Fauci told STAT: “Obviously that’s a concern whenever something like this happens, that it could erode public trust, yes.”

fauci-grimace.jpg

But he stressed that the FDA, when it reviews AstraZeneca’s vaccine for authorization, will make an independent decision.
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

Covid19 Vaccines Will Start Killing People 42 Days – 1 Year From Now Says Dr. Sherri Tenpenny

Postby smix » Wed Feb 17, 2021 7:09 pm

Covid19 Vaccines Will Start Killing People 42 Days – 1 Year From Now Says Dr. Sherri Tenpenny
ITN - In The News

URL: https://itnshow.com/2021/02/14/covid19- ... -tenpenny/
Category: healthNews
Published: February 14, 2021

Description: Dr. Sherry Tenpenny, a Cleveland-based doctor who has spent decades studying the effects of vaccines on humans, joined Reinette Senum to discuss the Covid19 vaccines that have come to market and the problems they present.



Dr. Tenpenny described the vaccines as an on button for your body’s auto-immune system without an off button, because of the messenger RNA (mRNA) technology the vaccines are based on. The Covid19 vaccines potentially harm the body in three ways Tenpenny says: by allowing the mRNA to replicate over and over within the body without being regulated, by causing diffuse injury to lung cells, and by killing type 2 macrophages. Type 2 macrophages are cells within the body that regulate the body’s response to a virus. Tenpenny says the true danger from these vaccines and the technology they’re based on is that they will have the potential to weaken the body’s natural – and already potent – response to other coronaviruses already in circulation. “A large number of people are going to start to get horribly sick and get all kinds of auto-immune diseases 42 days to maybe a year out and what are they going to do, these stupid doctors who say, ‘good for you for getting that vaccine,’ what are they going to say? ‘Oh it must be a mutant. We need to give an extra dose of that vaccine.’ Because now instead of one dose and two doses, we need three and four. Because the stupid physicians aren’t taking the time to learn anything about it,” Tenpenny said. “If I can learn this sitting in my living room reading a 19-page paper and several others, so can they,” she added.



We’re Not Being Told the Truth About Covid Vaccines Says Dr. Sherri Tenpenny
ITN - In The News

URL: https://itnshow.com/2021/02/16/were-not ... -tenpenny/
Category: healthNews
Published: February 16, 2021

Description: Dr. Sherry Tenpenny joined Reinette Senum to talk about the current Covid19 vaccines being distributed in the U.S. and the possible harmful effects that are associated with them. “We’ve been doing these vaccinations in America for a month. And in 30 days we have over 40,000 adverse events reported to the vaccine adverse events database. And it’s been estimated that less than 10% of adverse reactions that actually occur are reported to VAERS,” Tenpenny said. The Vaccine Adverse Event Reporting System (VAERS) is a database co-managed by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). It is an early warning system used to detect problems with vaccines administered in the U.S. Tenpenny, who has been an MD since 1985 and has spent the last two decades studying vaccines and their harmful effects, says we’re not being told the truth about the dangers of the Covid19 vaccines.



“Can you think of one single product in any industry, for as long as products have been made on the planet, that within 30 days we have 40,000 people complaining of side effects that not only is still on the market but is full-court press?” she asked. “And we’ve got paid actors telling us how great they are for getting their vaccine. We’re offering people $500 if they will just get their vaccine. And we’ve got nurses and doctors going ‘I got the vaccine! I got the vaccine!’ Well they’re not going to be so happy-dancy folks when they start to get their…ITP’s – their autoimmune reactions – that causes them to die of a blood disorder. They’re not going to be so happy-happy then. But we’re never going to see pictures of those people,” she added. “We are at a critical juncture in time for all of humanity on a lot of different levels. And we are past the time of hand-holding, pussy-footing around, being careful to not offend anybody and being so gentle with the snowflakes. We just can’t do it anymore.” Dr. Tenpenny says it will take between four and 14 months before we begin to see the full adverse effects brought on by the vaccines that are currently being given.



Something the makers of these vaccines will not be made to suffer any consequences for, says Senum. “That’s the other thing that’s really quite disconcerting for me is that there is this M.O. of industry, where if they can tell you, because they announced to us weeks ago, ‘don’t be concerned, people are going to die and they’re going to get maimed – just expect that,’” Senum said. “They have this methodology that if they can just tell you ahead of what they’re going to do, then they can do it. They have permission. And people are ok with this.”



Renowned OB/GYN Says Covid Vaccines Can Be Harmful to Pregnancy
ITN - In The News

URL: https://itnshow.com/2021/02/27/renowned ... pregnancy/
Category: healthNews
Published: February 27, 2021

Description: Dr. Christiane Northrup says the Covid vaccines that have recently come to market potentially pose threats to women who are pregnant. There is evidence Northrup says, that the vaccines cause inflammation in part of the placenta in pregnant women and called for data to be collected on this.



Northrup, an OB/GYN by training, a professor of 25 years and an author of three New York Times bestsellers, says thousands of adverse events have been reported to the Vaccine Adverse Events Reporting System (VAERS) so far. “And we’re not talking soreness at the injection site…no, no. We’re talking Bells-Palsey, ITP (Idiopathic Thrombocytopenia), where your platelets don’t clot your blood and you have a stroke.” “Here is the problem with my profession, OB/GYN,” Northrup says. “If anything happens after a vaccine, it’s never the vaccine. The entire profession has been brainwashed into the following narrative: vaccines are safe and effective. They are the most important public health measure ever invented for humanity.” “This goes into the brain and it is on repeat. It is MK-Ultra level programming,” Northrup said, referring to the CIA-sponsored mind-control program from the 1950s. “Those of you who have been through unbelievably expensive fertility treatment, maybe even mortgaged your house more than once or twice, and this precious baby, all of whose organs are being formed as we speak. You’re going to allow something that’s never been seen on the planet?” she said referring to the newly-developed mRNA technology the vaccines are based on. “Why? Because of a false narrative. And here’s the false narrative: ‘I’m gonna do my part. I’m doing my part to help others.’” Northrup implored women to follow their instincts and take steps to protect both themselves and their children. “I went into OB/GYN because this was the one field where I knew that women would do something for their health, when pregnant, that they would never do if they weren’t pregnant. So please, if you’re going to be the kind of mother who needs to stand up for the health of your child, you need to begin in pregnancy. You need to hold your ground.” “Women, wake up,” Northrup said. “Wake up!”
User avatar
smix
 
Posts: 2147856
Images: 1
Joined: Sat Aug 10, 2013 8:05 am
Blog: View Blog (0)

PreviousNext

  • Similar Topics
    Replies
    Views
    Last post

Return to Epidemiology - Contagious Diseases, Vaccines


Mobile Device
  • 1
  • FREE CLASSIFIED ADS
    Free Classified Ads
    There are 3 ways to advertise - your choice: you can place free ads in a forum topic, in the classified display ads section, or you may start your own free blog. Please select the appropriate category and forum for the ad content before you post. Do not spam.
    Caveat emptor - let the buyer beware. Deal at your own risk and peril.
  • Advertisement